UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended ~~June~~September 30, 2020

OR

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File No. 001-36894

SOLAREDGE TECHNOLOGIES, INC.

(Exact name of registrant as specified in its charter)

Delaware (State or other jurisdiction of incorporation or organization)		20-5338862 (IRS Employer Identification No.)
1 HaMada Street Herziliya Pituach 4673335, Israel (Address of principal executive offices, zip code)

~~972(9)~~972 (9) 957-6620
(Registrant’s telephone number, including area code)

		____________________________________________________________________

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common stock, par value $0.0001 per share	SEDG	NASDAQ (Global Select Market)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit ~~and post~~ such files).

Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated ~~filer,”~~filer”, “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☒		Accelerated filer	☐
Non-accelerated filer	☐	~~(Do not check if a smaller reporting company)~~	Smaller Reporting Company	☐
			Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by checkmark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes ☐ No ☒

As of ~~July~~October 30, 2020, there were ~~50,118,548~~51,211,402 shares of the registrant’s common stock, par value of $0.0001 per share, outstanding.

SOLAREDGE TECHNOLOGIES, INC.

FORM 10-Q

FOR THE QUARTER ENDED ~~June~~SEPTEMBER 30, 2020

INDEX




PART I. FINANCIAL INFORMATION	3
ITEM 1Financial Statements	3
Condensed Consolidated Balance Sheets as of ~~June~~September 30, 2020 (unaudited) and December 31, 2019	F-2 - F-3
Condensed Consolidated Statements of Income for the three and ~~six~~nine months ended ~~June~~September 30, ~~2020~~ 2020 and 2019 (unaudited)	F-4
Condensed Consolidated Statements of Comprehensive Income for the three and ~~six~~nine months ended ~~June~~September 30, 2020 and 2019 (unaudited)	F-5
Condensed Consolidated Statements of Changes in Stockholders’ Equity for the ~~six~~nine months ended ~~June~~September 30, 2020 and 2019 (unaudited)	F-6 - ~~F-7~~F-9
Condensed Consolidated Statements of Cash Flows for the ~~six~~nine months ended ~~June~~September 30, 2020 ~~and~~ and 2019 (unaudited)	~~F-8~~F-10 - ~~F-9~~F-11
Notes to the Condensed Consolidated Financial Statements (unaudited)	~~F-10~~F-12 - ~~F-24~~F-31
ITEM 2Management’s Discussion and Analysis of Financial Condition and Results of Operations	4
ITEM 3Quantitative and Qualitative Disclosures About Market Risk	1920
ITEM 4Controls and Procedures	21

PART II. OTHER INFORMATION	2122
ITEM 1Legal Proceedings	21
ITEM 1ARisk Factors	2123
ITEM 2Unregistered Sales of Equity Securities and Use of Proceeds	2223
ITEM 3Defaults upon Senior Securities	2223
ITEM 4Mine Safety Disclosures	2223
ITEM 5Other Information	2223
ITEM 6Exhibits	23

EXHIBIT INDEX	23

PART I. FINANCIAL INFORMATION

ITEM 1FINANCIAL STATEMENTS

SOLAREDGE TECHNOLOGIES, INC.

AND ITS SUBSIDIARIES

CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

AS OF ~~JUNE~~SEPTEMBER 30, 2020

IN U.S. DOLLARS

UNAUDITED

INDEX

	Page
Condensed Consolidated Balance Sheets as of ~~June~~September 30, 2020 (unaudited) and December 31, 2019	F-2 - F-3
Condensed Consolidated Statements of Income for the three and ~~six~~nine months ended ~~June~~September 30, 2020 ~~and~~ and 2019 (unaudited)	F-4
Condensed Consolidated Statements of Comprehensive Income for the three and ~~six~~nine months ended ~~June~~September 30, 2020 and 2019 (unaudited)	F-5
Condensed Consolidated Statements of Changes in Stockholders’ Equity for the ~~six~~nine months ended ~~June~~September 30, 2020 and 2019 (unaudited)	F-6 - ~~F-7~~F-9
Condensed Consolidated Statements of Cash Flows for the ~~six~~nine months ended ~~June~~September 30, 2020 and ~~2019~~ 2019 (unaudited)	~~F-8~~F-10 - ~~F-9~~F-11
Notes to the Condensed Consolidated Financial Statements (unaudited)	~~F-10~~F-12 - ~~F-24~~F-31

SOLAREDGE TECHNOLOGIES, INC.

AND ITS SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)

U.S. dollars in thousands (except share and per share data)

	June 30, 2020		December 31, 2019		September 30, 2020		December 31, 2019

ASSETS

CURRENT ASSETS:
Cash and cash equivalents	$	428,372	$	223,901	$	1,048,109	$	223,901
Short-term bank deposits		3,432		5,010		20,011		5,010
Restricted bank deposits		2,135		27,558		2,242		27,558
Marketable securities		113,032		91,845		110,585		91,845
Trade receivables, net of allowances of $6,273 and $2,473, respectively		181,700		298,383
Trade receivables, net of allowances of $6,690 and $2,473, respectively						183,141		298,383
Prepaid expenses and other current assets		79,867		115,268		83,866		115,268
Inventories, net		264,460		170,798		297,027		170,798

Total current assets		1,072,998		932,763		1,744,981		932,763

LONG-TERM ASSETS:
Marketable securities		45,684		119,176		21,003		119,176
Deferred tax assets, net						10,678		16,298
Other long-term assets						5,609		9,904
Property, plant and equipment, net						257,717		176,963
Operating lease right-of-use assets, net		36,951		35,858		36,965		35,858
Property, plant and equipment, net		226,416		176,963
Deferred tax assets, net		19,121		16,298
Intangible assets, net		68,211		74,008		68,122		74,008
Goodwill		128,279		129,654		133,221		129,654
Other long-term assets		8,166		9,904

Total long-term assets		532,828		561,861		533,315		561,861

Total assets	$	1,605,826	$	1,494,624	$	2,278,296	$	1,494,624

The accompanying notes are an integral part of the condensed consolidated financial statements.

	June 30, 2020			December 31, 2019			September 30, 2020			December 31, 2019

LIABILITIES AND STOCKHOLDERS' EQUITY

CURRENT LIABILITIES:
Trade payables, net	$	158,264		$	157,148		$	122,106		$	157,148
Employees and payroll accruals		48,764			47,390			50,814			47,390
Current maturities of bank loans and accrued interest		15,256			15,673			15,642			15,673
Warranty obligations		68,674			65,112			65,080			65,112
Deferred revenues and customers advances		25,625			70,815			27,267			70,815
Accrued expenses and other current liabilities		88,482			80,576			101,628			80,576

Total current liabilities		405,065			436,714			382,537			436,714

LONG-TERM LIABILITIES:
Bank loans		-			173
Convertible senior notes, net								570,332			-
Warranty obligations		124,010			107,451			130,614			107,451
Deferred revenues		103,181			89,982			109,439			89,982
Deferred tax liabilities, net								5,195			4,461
Operating lease liabilities		29,991			30,213			29,442			30,213
Deferred tax liabilities, net		1,112			4,461
Other long-term liabilities		17,666			13,960			18,700			14,133

Total long-term liabilities		275,960			246,240			863,722			246,240

COMMITMENTS AND CONTINGENT LIABILITIES

STOCKHOLDERS’ EQUITY:

Common stock of $0.0001 par value – Authorized: 125,000,000 shares as of June 30, 2020 and December 31, 2019; issued: 50,075,751 and 49,081,457 shares as of June 30, 2020 and December 31, 2019, respectively; outstanding: 50,075,751 and 48,898,062 shares as of June 30, 2020 and December 31, 2019, respectively.		5			5
Common stock of $0.0001 par value – Authorized: 125,000,000 shares as of September 30, 2020 and December 31, 2019; issued: 51,207,310 and 49,081,457 shares as of September 30, 2020 and December 31, 2019, respectively; outstanding: 51,207,310 and 48,898,062 shares as of September 30, 2020 and December 31, 2019, respectively.								5			5
Additional paid-in capital		511,640			475,792			574,326			475,792
Accumulated other comprehensive loss		(3,442	)		(1,809	)		(2,643	)		(1,809	)
Retained earnings		416,598			337,682			460,349			337,682

Total stockholders’ equity		924,801			811,670			1,032,037			811,670

Total liabilities and stockholders’ equity	$	1,605,826		$	1,494,624		$	2,278,296		$	1,494,624

The accompanying notes are an integral part of the condensed consolidated financial statements.


	Three months ended June 30,				Six months ended June 30,						Three months ended September 30,						Nine months ended September 30,
	2020		2019		2020			2019			2020			2019			2020			2019

Revenues	$	331,851	$	325,010	$	763,069		$	596,881		$	338,095		$	410,556		$	1,101,164		$	1,007,437
Cost of revenues		228,888		214,340		520,098			400,101			230,032			271,247			750,130			671,348

Gross profit		102,963		110,670		242,971			196,780			108,063			139,309			351,034			336,089

Operating expenses:

Research and development		38,098		29,505		74,793			55,704			40,817			30,747			115,610			86,451
Sales and marketing		20,936		22,127		45,189			42,299			21,924			22,026			67,113			64,325
General and administrative		13,964		13,685		30,149			25,376			14,928			12,214			45,077			37,590
Other operating income		-		-		(4,900	)		-
Other operating expenses (income)												-			8,305			(4,900	)		8,305

Total operating expenses		72,998		65,317		145,231			123,379			77,669			73,292			222,900			196,671

Operating income		29,965		45,353		97,740			73,401			30,394			66,017			128,134			139,418

Financial income (expenses), net		11,565		773		(5,040	)		(5,378	)
Financial expenses (income), net												(15,765	)		17,023			(10,725	)		22,401

Income before income taxes		41,530		46,126		92,700			68,023			46,159			48,994			138,859			117,017

Income taxes		4,862		13,213		13,784			17,135			2,408			7,270			16,192			24,405

Net income	$	36,668	$	32,913	$	78,916		$	50,888		$	43,751		$	41,724		$	122,667		$	92,612

Net loss attributable to Non-controlling interests		-		215		-			1,256
Net loss (income) attributable to Non-controlling interests												-			(97	)		-			1,159

Net income attributable to SolarEdge Technologies, Inc.	$	36,668	$	33,128	$	78,916		$	52,144		$	43,751		$	41,627		$	122,667		$	93,771

Net basic earnings per share of common stock attributable to SolarEdge Technologies, Inc.	$	0.74	$	0.69	$	1.59		$	1.10		$	0.87		$	0.86		$	2.46		$	1.97

Net diluted earnings per share of common stock attributable to SolarEdge Technologies, Inc.	$	0.70	$	0.66	$	1.51		$	1.05		$	0.83		$	0.81		$	2.33		$	1.87

Weighted average number of shares used in computing net basic earnings per share of common stock		49,786,586		47,683,799		49,493,173			47,353,401			50,529,691			48,195,020			49,842,399			47,637,023

Weighted average number of shares used in computing net diluted earnings per share of common stock		52,536,437		49,940,034		52,357,838			49,358,280			53,144,188			51,081,594			52,623,675			49,935,638

The accompanying notes are an integral part of the condensed consolidated financial statements.


	Three months ended June 30,						Six months ended June 30,						Three months ended September 30,						Nine months ended September 30,
	2020			2019			2020			2019			2020			2019			2020			2019

Net income	$	36,668		$	32,913		$	78,916		$	50,888		$	43,751		$	41,724		$	122,667		$	92,612

Other comprehensive income (loss):

Available-for-sale securities:
Changes in unrealized gains, net of tax		1,931			370			766			855
Changes in unrealized gains (losses), net of tax														(210	)		17			556			872
Reclassification adjustments for losses included in net income		-			(29	)		-			91			-			-			-			91
Net change		1,931			341			766			946			(210	)		17			556			963

Cash flow hedges:
Changes in unrealized gains, net of tax		343			-			881			-			85			-			966			-
Reclassification adjustments for losses included in net income		(435	)		-			(435	)		-
Reclassification adjustments for gains included in net income														(531	)		-			(966	)		-
Net change		(92	)		-			446			-			(446	)		-			-			-

Foreign currency translation adjustments, net		109			(16	)		(2,845	)		(1,317	)		1,455			(2,478	)		(1,390	)		(3,795	)

Total other comprehensive income (loss)		1,948			325			(1,633	)		(371	)		799			(2,461	)		(834	)		(2,832	)

Comprehensive income	$	38,616		$	33,238		$	77,283		$	50,517		$	44,550		$	39,263		$	121,833		$	89,780

Comprehensive income (loss) attributable to Non-controlling interests		-			(545	)		-			304
Comprehensive loss attributable to Non-controlling interests														-			286			-			590

Comprehensive income attributable to SolarEdge Technologies, Inc.	$	38,616		$	32,693		$	77,283		$	50,821		$	44,550		$	39,549		$	121,833		$	90,370

The accompanying notes are an integral part of the condensed consolidated financial statements.

	SolarEdge Technologies, Inc. Stockholders’ Equity																				SolarEdge Technologies, Inc. Stockholders’ Equity
	Common stock			Additional paid in Capital			Accumulated Other comprehensive loss			Retained earnings		Total			Non-controlling interests			Total stockholder’ equity			Common stock			Additional paid in Capital			Accumulated Other comprehensive loss			Retained earnings		Total			Non-controlling interests			Total stockholders’ equity
	Number	Amount		Additional paid in Capital			Accumulated Other comprehensive loss			Retained earnings		Total			Non-controlling interests			Total stockholder’ equity			Number	Amount		Additional paid in Capital			Accumulated Other comprehensive loss			Retained earnings		Total			Non-controlling interests			Total stockholders’ equity

Balance as of January 1, 2019	46,052,802	$	5	$	371,794		$	(524	)	$	191,133	$	562,408		$	8,318		$	570,726		46,052,802	$	5	$	371,794		$	(524	)	$	191,133	$	562,408		$	8,318		$	570,726

Issuance of Common Stock upon exercise of employee and nonemployees stock-based awards	254,515		* -		309			-			-		309			-			309		254,515		* -		309			-			-		309			-			309
Equity based compensation expenses to employees and nonemployee	-		-		9,704			-			-		9,704			-			9,704		-		-		9,704			-			-		9,704			-			9,704
Issuance of Common stock upon business combination	1,194,046		* -		34,601			-			-		34,601			-			34,601		1,194,046		* -		34,601			-			-		34,601			-			34,601
Non-controlling interests related to business combination	-		-		-			-			-		-			67,734			67,734		-		-		-			-			-		-			67,734			67,734
Change in non-controlling interests	-		-		977			-			-		977			(2,964	)		(1,987	)	-		-		977			-			-		977			(2,964	)		(1,987	)
Other comprehensive loss adjustments	-		-		-			(696	)		-		(696	)		(849	)		(1,545	)	-		-		-			(696	)		-		(696	)		(849	)		(1,545	)
Net income	-		-		-			-			19,016		19,016			(1,041	)		17,975		-		-		-			-			19,016		19,016			(1,041	)		17,975

Balance as of March 31, 2019	47,501,363	$	5	$	417,385		$	(1,220	)	$	210,149	$	626,319		$	71,198		$	697,517		47,501,363	$	5	$	417,385		$	(1,220	)	$	210,149	$	626,319		$	71,198		$	697,517

Issuance of Common Stock upon exercise of employee and nonemployees stock-based awards	466,062		-		3,455			-			-		3,455			-			3,455		466,062		-		3,455			-			-		3,455			-			3,455
Equity based compensation expenses to employees and nonemployee	-		-		11,372			-			-		11,372			-			11,372		-		-		11,372			-			-		11,372			-			11,372
Change in non-controlling interests	-		-		(528	)		-			-		(528	)		(65,551	)		(66,079	)	-		-		(528	)		-			-		(528	)		(65,551	)		(66,079	)
Other comprehensive income adjustments	-		-		-			325			-		325			545			870		-		-		-			325			-		325			545			870
Net income	-		-		-			-			33,128		33,128			(215	)		32,913		-		-		-			-			33,128		33,128			(215	)		32,913

Balance as of June 30, 2019	47,967,425	$	5	$	431,684		$	(895	)	$	243,277	$	674,071		$	5,977		$	680,048		47,967,425	$	5	$	431,684		$	(895	)	$	243,277	$	674,071		$	5,977		$	680,048

The accompanying notes are an integral part of the condensed consolidated financial statements.

	SolarEdge Technologies, Inc. Stockholders’ Equity																		SolarEdge Technologies, Inc. Stockholders’ Equity
	Common stock			Additional paid in Capital		Accumulated Other comprehensive loss			Retained earnings		Total			Non-controlling interests		Total stockholder’ equity			Common stock			Additional paid in Capital			Accumulated Other comprehensive loss			Retained earnings		Total			Non-controlling interests			Total stockholders’ equity
	Number	Amount		Additional paid in Capital		Accumulated Other comprehensive loss			Retained earnings		Total			Non-controlling interests		Total stockholder’ equity			Number	Amount		Additional paid in Capital			Accumulated Other comprehensive loss			Retained earnings		Total			Non-controlling interests			Total stockholders’ equity

Balance as of January 1, 2020	48,898,062	$	5	$	475,792	$	(1,809	)	$	337,682	$	811,670		$	-	$	811,670
Balance as of June 30, 2019																			47,967,425	$	5	$	431,684		$	(895	)	$	243,277	$	674,071		$	5,977		$	680,048
					-
Issuance of Common Stock upon exercise of employee and nonemployees stock-based awards	701,431		* -		3,308		-			-		3,308			-		3,308		608,863		* -		1,176			-			-		1,176			-			1,176
Equity based compensation expenses to employees and nonemployee	-		-		12,773		-			-		12,773			-		12,773		-		-		17,609			-			-		17,609			-			17,609
Change in non-controlling interests																			-		-		(10	)		-			-		(10	)		(612	)		(622	)
Other comprehensive loss adjustments	-		-		-		(3,581	)		-		(3,581	)		-		(3,581	)	-		-		-			(2,461	)		-		(2,461	)		(286	)		(2,747	)
Net income	-		-		-		-			42,248		42,248			-		42,248		-		-		-			-			41,627		41,627			97			41,724

Balance as of March 31, 2020	49,599,493	$	5	$	491,873	$	(5,390	)	$	379,930	$	866,418		$	-	$	866,418

Issuance of Common Stock upon exercise of employee and nonemployees stock-based awards	476,258		* -		5,806		-			-		5,806			-		5,806
Equity based compensation expenses to employees and nonemployee	-		-		13,961		-			-		13,961			-		13,961
Other comprehensive income adjustments	-		-		-		1,948			-		1,948			-		1,948
Net income	-		-		-		-			36,668		36,668			-		36,668

Balance as of June 30, 2020	50,075,751	$	5	$	511,640	$	(3,442	)	$	416,598	$	924,801		$	-	$	924,801
Balance as of September 30, 2019																			48,576,288	$	5	$	450,459		$	(3,356	)	$	284,904	$	732,012		$	5,176		$	737,188

The accompanying notes are an integral part of the condensed consolidated financial statements.

CONDENSED CONSOLIDATED STATEMENTS OF ~~CASH FLOWS~~STOCKHOLDERS’ EQUITY (Unaudited)

Six months ended
June 30,
2020
2019

Cash flows provided by operating activities:
Net income
$
78,916
$
50,888
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation of property, plant and equipment
10,646
8,147
Amortization of intangible assets
4,615
4,895
Amortization of premium and accretion of discount on available-for-sale marketable securities, net
373
(12
)
Stock-based compensation expenses
26,734
21,076
Deferred income tax benefit, net
(6,424
)
(1,960
)
Other adjustments, net
(1
)
643
Changes in assets and liabilities:
Inventories, net
(94,230
)
1,723
Prepaid expenses and other assets
37,066
(2,574
)
Trade receivables, net
116,045
(56,562
)
Operating lease right-of-use assets and liabilities, net and effect of exchange rate differences
(451
)
1,466
Trade payables, net
(1,823
)
5,493
Employees and payroll accruals
1,457
5,151
Warranty obligations
20,198
28,860
Deferred revenues and customers advances
(31,834
)
11,764
Other liabilities
5,768
28,236

Net cash provided by operating activities
167,055
107,234

Cash flows from investing activities:
Proceeds from sales and maturities of available-for-sale marketable securities
89,739
68,407
Purchase of property, plant and equipment
(53,706
)
(22,244
)
Investment in available-for-sale marketable securities
(36,815
)
(63,655
)
Withdrawal from (investment in) restricted bank deposits
25,634
(203
)
Business combination, net of cash acquired
-
(38,435
)
Other investing activities
2,024
3,909

Net cash provided by (used in) in investing activities
$
26,876
$
(52,221
)

	SolarEdge Technologies, Inc. Stockholders’ Equity
	Common stock			Additional paid in Capital		Accumulated Other comprehensive loss			Retained earnings		Total			Non-controlling interests		Total stockholders’ equity
	Number	Amount		Additional paid in Capital		Accumulated Other comprehensive loss			Retained earnings		Total			Non-controlling interests		Total stockholders’ equity

Balance as of January 1, 2020	48,898,062	$	5	$	475,792	$	(1,809	)	$	337,682	$	811,670		$	-	$	811,670
					-
Issuance of Common Stock upon exercise of employee and nonemployees stock-based awards	701,431		* -		3,308		-			-		3,308			-		3,308
Equity based compensation expenses to employees and nonemployee	-		-		12,773		-			-		12,773			-		12,773
Other comprehensive loss adjustments	-		-		-		(3,581	)		-		(3,581	)		-		(3,581	)
Net income	-		-		-		-			42,248		42,248			-		42,248

Balance as of March 31, 2020	49,599,493	$	5	$	491,873	$	(5,390	)	$	379,930	$	866,418		$	-	$	866,418

Issuance of Common Stock upon exercise of employee and nonemployees stock-based awards	476,258		* -		5,806		-			-		5,806			-		5,806
Equity based compensation expenses to employees and nonemployee	-		-		13,961		-			-		13,961			-		13,961
Other comprehensive income adjustments	-		-		-		1,948			-		1,948			-		1,948
Net income	-		-		-		-			36,668		36,668			-		36,668

Balance as of June 30, 2020	50,075,751	$	5	$	511,640	$	(3,442	)	$	416,598	$	924,801		$	-	$	924,801

The accompanying notes are an integral part of the condensed consolidated financial statements.

	SolarEdge Technologies, Inc. Stockholders’ Equity
	Common stock			Additional paid in Capital		Accumulated Other comprehensive loss			Retained earnings		Total		Non-controlling interests		Total stockholders’ equity
	Number	Amount		Additional paid in Capital		Accumulated Other comprehensive loss			Retained earnings		Total		Non-controlling interests		Total stockholders’ equity

Balance as of June 30, 2020	50,075,751	$	5	$	511,640	$	(3,442	)	$	416,598	$	924,801	$	-	$	924,801

Issuance of Common Stock upon exercise of employee and nonemployees stock-based awards	1,131,559		* -		10,091		-			-		10,091		-		10,091
Equity based compensation expenses to employees and nonemployee	-		-		16,259		-			-		16,259		-		16,259
Equity component of convertible senior notes, net	-		-		36,336		-			-		36,336		-		36,336
Other comprehensive income adjustments	-		-		-		799			-		799		-		799
Net income	-		-		-		-			43,751		43,751		-		43,751

Balance as of September 30, 2020	51,207,310	$	5	$	574,326	$	(2,643	)	$	460,349	$	1,032,037	$	-	$	1,032,037

The accompanying notes are an integral part of the condensed consolidated financial statements.

Six months ended
June 30,
2020
2019

Cash flows from financing activities:
Repayment of bank loans
$
(15,119
)
$
(4,891
)
Proceeds from bank loans
15,113
216
Proceeds from issuance of shares under stock purchase plan and upon exercise of stock-based awards
9,114
3,764
Change in Non-controlling interests
-
(66,474
)
Other financing activities
(112
)
-

Net cash provided by (used in) financing activities
8,996
(67,385
)

Increase (decrease) in cash and cash equivalents
202,927
(12,372
)
Cash and cash equivalents at the beginning of the period
223,901
187,764
Effect of exchange rate differences on cash and cash equivalents
1,544
1,183

Cash and cash equivalents at the end of the period
$
428,372
$
176,575

Supplemental disclosure of non-cash activities:
Purchase of property, plant and equipment
$
8,070
$
-
Operating lease, right of use asset
$
980
$
38,374

	Nine months ended September 30,
	2020			2019

Cash flows provided by operating activities:
Net income	$	122,667		$	92,612
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation of property, plant and equipment		16,376			12,532
Amortization of intangible assets		7,081			7,514
Amortization of debt discount and debt issuance costs		168			-
Amortization of premium and accretion of discount on available-for-sale marketable securities, net		602			-
Stock-based compensation expenses		42,993			38,685
Deferred income tax benefit, net		(5,263	)		(4,923	)
Other adjustments, net		224			657
Changes in assets and liabilities:
Inventories, net		(121,999	)		15,746
Prepaid expenses and other assets		37,871			(19,795	)
Trade receivables, net		118,044			(114,572	)
Operating lease right-of-use assets and liabilities, net and effect of exchange rate differences		(459	)		2,138
Trade payables, net		(35,499	)		21,301
Employees and payroll accruals		3,132			15,329
Warranty obligations		23,155			49,633
Deferred revenues and customers advances		(24,283	)		19,516
Other liabilities		10,619			39,561

Net cash provided by operating activities		195,429			175,934

Cash flows from investing activities:
Proceeds from sales and maturities of available-for-sale marketable securities		116,419			119,570
Purchase of property, plant and equipment		(90,553	)		(39,679	)
Investment in available-for-sale marketable securities		(36,781	)		(103,711	)
Withdrawal from (investment in) restricted bank deposits		25,538			(243	)
Business combination, net of cash acquired		-			(38,435	)
Withdrawal from (investment in) bank deposits		(14,667	)		4,101
Other investing activities		743			-

Net cash provided by (used in) in investing activities	$	699		$	(58,397	)

The accompanying notes are an integral part of the condensed consolidated financial statements.

a.SolarEdge Technologies, Inc. (the “Company”) and its subsidiaries design, develop, and sell an intelligent inverter solution designed to maximize power generation at the individual photovoltaic (“PV”) module level while lowering the cost of energy produced by the solar PV system and providing comprehensive and advanced safety features. The Company’s products consist mainly of (i) power optimizers designed to maximize energy throughput from each and every module of a solar PV system through constant tracking of Maximum Power Point individually per module, (ii) inverters which invert direct current (DC) from the PV module to alternating current (AC), (iii) a related cloud-based monitoring platform, that collects and processes information from the power optimizers and inverters of a solar PV system to enable customers and system owners as applicable, to monitor and manage the applicable solar PV system and (iv) a storage solution that is used to increase energy independence and maximize self-consumption for homeowners by utilizing a battery that is sold separately by third party manufacturers, to store and supply power as needed.

The Company and its subsidiaries sell their intelligent inverter solution products worldwide through large distributors and electrical equipment wholesalers to smaller solar installers as, well as directly to large solar installers and engineering, procurement and construction firms (“EPCs”).

The Company has expanded its activity to other areas of smart energy technology through acquisitions. The Company now offers energy solutions which include lithium-ion cells, batteries and energy storage systems (“Energy Storage”), electric vehicle, or EV components and charging capabilities (“e-Mobility”), ~~as well as~~ uninterrupted power supply solutions (“UPS”), as well as the manufacture of automated machines for industries (“Automation Machines”).

In August 2020, the FASB issued ASU No. 2020-06, Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (ASU 2020-06), which simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts in an entity’s own equity. Among other changes, ASU 2020-06 removes from U.S. GAAP the liability and equity separation model for convertible instruments with a cash conversion feature, and as a result, after adoption, entities will no longer separately present in equity an embedded conversion feature for such debt. Similarly, the embedded conversion feature will no longer be amortized into income as interest expense over the life of the instrument. Instead, entities will account for a convertible debt instrument wholly as debt unless (1) a convertible instrument contains features that require bifurcation as a derivative under ASC Topic 815, Derivatives and Hedging, or (2) a convertible debt instrument was issued at a substantial premium. Among other potential impacts, this change is expected to reduce reported interest expense, increase reported net income, and result in a reclassification of certain conversion feature balance sheet amounts from stockholders’ equity to liabilities as it relates to the Company’s convertible senior notes. Additionally, ASU 2020-06 requires the application of the if-converted method to calculate the impact of convertible instruments on diluted earnings per share (EPS), which is consistent with the Company’s accounting treatment under the current standard. ASU 2020-06 is effective for fiscal years beginning after December 15, 2021, with early adoption permitted for fiscal years beginning after December 15, 2020, and can be adopted on either a fully retrospective or a modified retrospective basis. The Company is currently evaluating the timing, method of adoption and overall impact of this standard on its consolidated financial statements.

In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (ASU) No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. The FASB subsequently issued amendments to ASU 2016-13, which have the same effective date and transition date of January 1, 2020. This standard requires entities to estimate an expected lifetime credit loss on financial assets ranging from short-term trade accounts receivable to long-term financings and report credit losses using an expected losses model rather than the incurred losses model that was previously used, and establishes additional disclosures related to credit risks. For available-for-sale (“AFS”) debt securities with unrealized losses, the standard eliminates the concept of other-than-temporary impairments and requires allowances to be recorded instead of reducing the amortized cost of the investment.

This standard limits the amount of credit losses to be recognized for AFS debt securities to the amount by which carrying value exceeds fair value and requires the reversal of previously recognized credit losses if fair value increases.

The Company adopted Topic 326 effective January 1, 2020, based on the composition of the Company’s trade receivables, investment portfolio and other financial assets, current economic conditions and historical credit loss activity. The adoption of this standard did not have a material impact on the Company’s consolidated financial statements.

The condensed consolidated financial statements for the ~~six~~nine months ended ~~June~~September 30, 2020 are presented under the new standard, while comparative periods presented are not adjusted and continue to be reported in accordance with the Company’s historical accounting policy (see Note 7).

The ~~accompanying~~ unaudited condensed consolidated ~~interim~~ financial statements and accompanying notes have been prepared in accordance with Article 10 of Regulation S-X, “Interim Financial Statements” and the rules and regulations for Form 10-Q of the Securities and Exchange Commission (the “SEC”). Pursuant to those rules and regulations, the Company has condensed or omitted certain information and disclosures in footnotes that it normally includes in its annual consolidated financial statements prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”).

In management’s opinion, the ~~Company has made all adjustments (consisting only of normal, recurring adjustments, except as otherwise indicated) necessary to fairly present its~~unaudited condensed consolidated financial ~~position,~~statements reflect all adjustments of a normal recurring nature that are necessary for a fair presentation of the results ~~of operations, and cash flows.~~for the interim periods presented. The Company’s interim period ~~operating~~ results do not necessarily indicate the results that may be expected for any other interim period or for the full fiscal year.

The significant accounting policies applied in the annual consolidated financial statements of the Company as of December 31, 2019, contained in the Company’s Annual Report on Form 10-K filed with the SEC on February 27, 2020, have been applied consistently in these unaudited interim condensed consolidated financial statements, except for ASC 815 - Derivatives and Hedging (see Note 6) ~~and~~, the adoption of ASU No. 2016-13, Financial Instruments - Credit Losses (Topic 326) (see Note 7) and ASC 470-20 "Debt with Conversion and Other Options" (see Note 8).

The Company depends on two contract manufacturers and several limited or single source component suppliers. Reliance on these vendors makes the Company vulnerable to possible capacity constraints and reduced control over component availability, delivery schedules, manufacturing yields, and costs. These two contract manufacturers collectively accounted for ~~54.7%~~47.4% and 42.3% of the Company’s trade payables as of ~~June~~September 30, 2020 and December 31, 2019, respectively.

In September 2020 the Company has commenced the production ramp up of its manufacturing facility in the North of Israel, “Sella 1”. The Company expects ramp up to continue until the second quarter of 2021.

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, costs and expenses and related disclosures in the accompanying notes.

The duration, scope and effects of the ongoing COVID-19 pandemic, government and other third party responses to it, and the related macroeconomic effects, including to the Company’s business and the business of the Company’s suppliers and customers are uncertain, rapidly changing and difficult to predict. As a result, the Company’s accounting estimates and assumptions may change over time in response to this evolving situation. Such changes could result in future impairments of goodwill, intangibles, long-lived assets, inventories, incremental credit losses on receivables and AFS debt securities, or an increase in the Company’s insurance liabilities as of the time of a relevant measurement event.

f.g.Certain prior period amounts have been reclassified to conform to the current period presentation.

The following table summarizes the AFS marketable debt securities as of ~~June~~September 30, 2020:

	Amortized cost		Gross unrealized gains		Gross unrealized losses			Fair value		Amortized cost		Gross unrealized gains		Gross unrealized losses			Fair value

AFS – matures within one year:
Corporate bonds	$	111,956	$	1,082	$	(6	)	$	113,032	$	108,306	$	878	$	(11	)	$	109,173
Governmental bonds											1,398		14		-			1,412
											109,704		892		(11	)		110,585

AFS – matures after one year:
Corporate bonds		44,081		331		(143	)		44,269		20,822		184		(3	)		21,003
Governmental bonds		1,398		17		-			1,415
		45,479		348		(143	)		45,684

Total	$	157,435	$	1,430	$	(149	)	$	158,716	$	130,526	$	1,076	$	(14	)	$	131,588

The following table summarizes the AFS marketable debt securities as of December 31, 2019:

As of ~~June~~September 30, 2020, the Company did not record an allowance for credit losses for its AFS marketable debt ~~securities (See Note 7).~~securities.

Changes in the Company’s product warranty obligations for the ~~six~~nine months ended ~~June~~September 30, 2020 and 2019 were as follows:

	Six months ended June 30,						Nine months ended September 30,
	2020			2019			2020			2019


Balance, at beginning of period	$	172,563		$	121,826		$	172,563		$	121,826
Additions and adjustments to cost of revenues		47,369			46,288			74,465			79,791
Usage and current warranty expenses		(27,248	)		(17,476	)		(51,334	)		(30,263	)

Balance, at end of period		192,684			150,638			195,694			171,354
Less current portion		(68,674	)		(38,819	)		(65,080	)		(45,887	)

Long-term portion	$	124,010		$	111,819		$	130,614		$	125,467

In accordance with ASC 820, the Company measures its cash equivalents, foreign currency derivative contracts, and marketable securities, at fair value using the market approach valuation technique. Cash equivalents and marketable securities are classified within Level 1 or Level 2 based on whether these assets are valued using quoted market prices or alternative pricing sources and models utilizing market observable inputs. Foreign currency derivative contracts are classified within the Level 2 value hierarchy, as the valuation inputs are based on quoted prices and market observable data of similar instruments.

The following table sets forth the Company’s assets that were measured at fair value as of ~~June~~September 30, 2020 and December 31, 2019, by level within the fair value hierarchy:

		Fair value measurements as of					Fair value measurements as of
	Fair Value	June 30,		December 31,		Fair Value	September 30,			December 31,
Description	Hierarchy	2020		2019		Hierarchy	2020			2019


Assets:
Cash equivalents:
Money market mutual funds	Level 1	$	72,321	$	527	Level 1	$	721,088		$	527

Derivative instruments asset:
Forward contracts designated as hedging instruments	Level 2	$	508	$	-
Options and forward contracts not designated as hedging instruments	Level 2	$	478	$	-	Level 2	$	780		$	-

Short-term marketable securities:
Corporate bonds	Level 2	$	113,032	$	91,845	Level 2	$	109,173		$	91,845
Governmental bonds						Level 2	$	1,412		$	-

Long-term marketable securities:
Corporate bonds	Level 2	$	44,269	$	117,778	Level 2	$	21,003		$	117,778
Governmental bonds	Level 2	$	1,415	$	1,398	Level 2	$	-		$	1,398

Liabilities:
Derivative instruments liability:
Options and forward contracts not designated as hedging instruments						Level 2	$	(1,119	)	$	-

The Company accounts for derivatives and hedging based on ASC 815 (“Derivatives and Hedging”). ASC 815 requires the Company to recognize all derivatives on the balance sheet at fair value. The accounting for changes in the fair value (i.e., gains or losses) of a derivative instrument depends on whether it has been designated and qualifies as part of a hedging relationship and further, on the type of hedging relationship.

To protect against the increase in value of forecasted foreign currency cash flows resulting from salary denominated in the Israeli currency, the New Israeli Shekels (“NIS”), during the ~~six~~nine months ended ~~June~~September 30, 2020, the Company instituted a foreign currency cash flow hedging ~~program. The Company hedges~~program whereby portions of the anticipated payroll denominated in NIS for a period of one to six months with hedging contracts.

Accordingly, when the dollar strengthens against the NIS, the decline in present value of future foreign currency expenses is offset by losses in the fair value of the hedging contracts. Conversely, when the dollar weakens, the increase in the present value of future foreign currency cash flows is offset by gains in the fair value of the hedging contracts. These hedging contracts are designated as cash flow hedges, as defined by ASC 815 and are all effective hedges.

As of ~~June~~September 30, 2020, the Company ~~entered into forward contracts to sell U.S. dollars for NIS in the amount of $9,027.~~

~~In addition to the above-mentioned~~had no derivative instruments that were designated as cash flow ~~hedges transactions, the~~hedges.

The Company also entered into derivative instrument arrangements to hedge the Company’s exposure to currencies other than the U.S. dollar. These derivative instruments are not designated as cash flow hedges, as defined by ASC 815, and therefore all gains and losses, resulting from fair value remeasurement, were recorded immediately in the statement of income, as a financial ~~income (expenses)~~expense (income), net.

As of ~~June~~September 30, 2020, the Company entered into forward contracts to sell Australian dollars (“AUD”) for U.S. dollars in the amount of AUD 157.5 million.

As of ~~June~~September 30, 2020, the Company entered into put and call options to sell Euro ("EUR") for U.S. dollars in the amount of ~~euros~~EUR 45 million.

As of September 30, 2020, the Company entered into put and call options to sell U.S. dollars for South Korean Won in the amount of USD 48.6 million.

The fair value of derivative assets as of ~~June~~September 30, 2020, was ~~$986,~~$780, which was recorded in prepaid expenses and other current assets in the Condensed Consolidated Balance Sheets.

The fair value of derivative liabilities as of September 30, 2020, was $1,119, which was recorded in accrued expenses and other current liabilities in the Condensed Consolidated Balance Sheets.

As of December 31, 2019 and for the year then ended, the Company had no derivative instruments (see Note 5).

For the ~~six~~three and nine months ended ~~June~~September 30, 2020, the Company recorded ~~unrealized gain~~a loss in the amount of ~~$446, net of tax effect, in “accumulated other comprehensive loss” related to the derivative assets designated as hedging instruments.~~

~~For the six months ended June 30, 2020, the Company recorded gain in the amount of $491,~~$1,450 and $959, respectively, in “financial ~~expenses,~~income, net” related to the derivative assets not designated as hedging instruments.

~~The Company had no gains or losses related to derivative instruments during the six months ended June 30, 2019.~~

The following table provides details about reclassifications out of accumulated other comprehensive income (loss) ~~for the three and six months ended June 30, 2020 and 2019:~~:

Details about Accumulated Other Comprehensive Loss Components	Amount Reclassified from Accumulated Other Comprehensive Loss					Affected Line Item in the Statements of Income
Details about Accumulated Other Comprehensive Income (Loss) Components							Amount Reclassified from Accumulated Other Comprehensive Loss										Affected Line Item in the Statements of Income
							Three months ended					Nine months ended
							September 30, 2020					September 30, 2020
	2020			2019			2020			2019		2020			2019

Unrealized gains on cash flow hedges, net	$	99		$	-	Cost of revenues	$	90		$	-	$	189		$	-	Cost of revenues
		270			-	Research and development		353			-		623			-	Research and development
		61			-	Sales and marketing		75			-		136			-	Sales and marketing
		66			-	General and administrative		87			-		153			-	General and administrative

		496			-	Total, before income taxes		605			-		1,101			-	Total, before income taxes

		(61	)		-	Income tax expense		(74	)		-		(135	)		-	Income tax expense

	$	435		$	-	Total, net of income taxes	$	531		$	-	$	966		$	-	Total, net of income taxes

Effective January 1, 2020, the Company adopted ASU 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, prospectively. This ASU replaces the incurred loss impairment model with an expected credit loss impairment model for financial instruments, including trade receivables. The adoption of this standard did not have a material impact on the Company’s condensed consolidated financial statements.

The amendment requires entities to consider forward-looking information to estimate expected credit losses, resulting in earlier recognition of losses for receivables that are current or not yet due, which were not considered under the previous accounting guidance. As stated above, the Company did not record a noncash cumulative effect adjustment on the opening consolidated balance sheet as of January 1, 2020, due to immateriality.

The Company is exposed to credit losses primarily through sales of products. The Company’s expected loss allowance methodology for accounts receivable is developed using historical collection experience, current and future economic and market conditions and a review of the ~~current~~ status of customers' trade accounts receivables.

Due to the short-term nature of such receivables, the estimate of amount of accounts receivable that may not be collected is based on aging of the accounts receivable balances, the financial condition of customers and the Company’s historical experience with similar customers. Additionally, specific allowance amounts are established to record the appropriate provision for customers that have a higher probability of default.

The Company’s monitoring activities include timely account reconciliation, dispute resolution, payment confirmation, consideration of customers' financial condition and macroeconomic conditions. Balances are written off when determined to be uncollectible. The Company considered the current and expected future economic and market conditions surrounding the COVID-19 pandemic and determined that the estimate of credit losses was not significantly impacted as of ~~June~~September 30, 2020. Estimates are used to determine the allowance. The allowance is based on assessment of anticipated payment and other historical, current and future information that is reasonably available.

The following table provides a roll-forward of the allowance for credit losses that is deducted from the amortized cost basis of trade receivables to present the net amount expected to be collected:

	Six months ended June 30,			Nine months ended September
	2020			30, 2020


Balance, at beginning of period	$	2,473		$	2,473
Provision for expected credit losses		4,296			4,595
Amounts written off charged against the allowance and others		(496	)		(378	)

Balance, at end of period	$	6,273		$	6,690

On September 25, 2020, the Company sold $632,500 aggregate principal amount of its 0.00% convertible senior notes due 2025 (the “Notes”). The Notes were sold pursuant to an indenture, dated September 25, 2020 (the “Indenture”), between the Company and U.S. Bank National Association, as trustee (the “Trustee”). The Notes do not bear regular interest and mature on September 15, 2025, unless earlier repurchased or converted in accordance with their terms. The Notes are general senior unsecured obligations of the Company. Holders may convert their Notes prior to the close of business on the business day immediately preceding June 15, 2025 in multiples of $1,000 principal amount, only under the following circumstances: (1) during any calendar quarter commencing after the calendar quarter ending on December 31, 2020 (and only during such calendar quarter), if the last reported sale price of the common stock for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day; (2) during the five-business-day period after any five consecutive trading day period in which the trading price per $1,000 principal amount of the Notes for each trading day of that five consecutive trading day period was less than 98% of the product of the last reported sale price of the common stock and the conversion rate on each such trading day; or (3) upon the occurrence of specified corporate events as described in the Indenture. In addition, holders may convert their Notes, in multiples of $1,000 principal amount, at their option at any time beginning on or after June 15, 2025, and prior to the close of business on the second scheduled trading day immediately preceding the stated maturity date of the Notes, without regard to the foregoing circumstances.

The initial conversion rate for the Notes was 3.5997 shares of common stock per $1,000 principal amount of Notes, which is equivalent to an initial conversion price of approximately $277.80 per share of common stock, subject to adjustment upon the occurrence of certain specified events as set forth in the Indenture. Upon conversion, the Company may choose to pay or deliver, as the case may be, cash, shares of common stock or a combination of cash and shares of common stock.

In addition, upon the occurrence of a fundamental change (as defined in the Indenture), holders of the Notes may require the Company to repurchase all or a portion of their Notes, in multiples of $1,000 principal amount, at a repurchase price of 100% of the principal amount of the Notes, plus any accrued and unpaid special interest, if any, to, but excluding, the repurchase date. If certain fundamental changes referred to as make-whole fundamental changes occur, the conversion rate for the Notes may be increased.

The Company accounts for its Notes in accordance with ASC 470-20 "Debt with Conversion and Other Options". The Company separately accounts for the liability and equity components of convertible debt instruments. The liability component at issuance is recognized at fair value, based on the fair value of a similar instrument that does not have a conversion feature. The equity component is based on the excess of the principal amount of the debentures over the fair value of the liability component, after adjusting for an allocation of debt issuance costs, and is recorded in additional paid-in capital. Debt discount is amortized as additional non-cash interest expense over the expected life of the debt using the effective interest rate method. In accounting for the issuance costs related to the Notes, the issuance costs incurred were allocated between the liability and equity components based on their relative values.

The Company’s Notes are included in the calculation of diluted EPS if the assumed conversion into common shares is dilutive, using the “if-converted” method. This involves adding back the periodic interest expense net of tax associated with the Notes to the numerator and by adding the shares that would be issued in an assumed conversion (regardless of whether the conversion option is in or out of the money) to the denominator for the purposes of calculating diluted EPS, unless the Notes are antidilutive (See Note 11).

The Convertible Senior Notes consisted of the following as of September 30, 2020:

As of September 30, 2020, the debt discount and debt issuance costs of the Notes will be amortized over the remaining period of approximately 5 years.

The annual effective interest rate of the liability component is 2.10% for the Notes which remains unchanged from the Notes issuance date.

The following table presents the total amount of interest expenses recognized related to the Notes for the three and nine months ended September 30, 2020:

Total initial issuance costs of $14,632 related to the Notes were allocated between the liability and equity components in the same proportion as the allocation of the total proceeds to the liability and equity components. Issuance costs attributable to the liability component are being amortized to interest expense over the respective term of the Notes using the effective interest rate method. The issuance costs attributable to the equity component were netted against the respective equity component in additional paid-in capital. The Company initially allocated issuance costs of $13,502 and $1,130 to the liability and equity components, respectively.

As of September 30, 2020, the if-converted value of the Notes did not exceed the principal amount.

As of ~~June~~September 30, 2020, contingent liabilities exist regarding guarantees in the amounts of $18,643, ~~$2,160~~$2,176 and ~~$75~~$240 in respect of bank loans, office rent lease agreements and other transactions, respectively.

These contractual purchase obligations relate to inventories held by contract manufacturers and purchase orders initiated by the contract manufacturers and suppliers, which cannot be cancelled without penalty. The Company utilizes third parties to manufacture its products. In addition, it acquires raw materials or other goods and services, including product components, by issuing to suppliers authorizations to purchase based on its projected demand and manufacturing needs.

As of ~~June~~September 30, 2020, the Company had non-cancellable purchase obligations totaling approximately ~~$335,321~~$326,661 out of which the Company already recorded a provision for loss in the amount of ~~$3,811.~~$3,118.

As of ~~June~~September 30, 2020, the Company had off-balance sheet contractual obligations for capital expenditures totaling approximately ~~$80,251.~~$114,526. These commitments reflect purchases of automated assembly lines and other machinery related to the Company’s manufacturing.

From time to time, the Company may be involved in various claims and legal proceedings. The Company reviews the status of each matter and assesses its potential financial exposure.

If the potential loss from any claim or legal proceeding is considered probable and the amount can be reasonably estimated, the Company accrues a liability for the estimated loss.

These accruals are reviewed at least quarterly and adjusted to reflect the impact of negotiations, settlements, rulings, advice of legal counsel and other information and events pertaining to a particular matter.

In September 2018, the Company’s German subsidiary, SolarEdge Technologies GmbH received a complaint filed by competitor SMA Solar Technology AG (“SMA”). The complaint, filed in the District Court Düsseldorf, Germany, alleges that SolarEdge's 12.5kW - 27.6kW inverters infringe two of the plaintiff’s patents. In its complaint, SMA requests inter alia an injunction and a determination for a claim for damages for sales in Germany. Plaintiff also ~~asserts~~asserted a value in dispute of 5EUR 5.5 million ~~Euros~~ (approximately ~~$5,600)~~$6,450) for both patents. ~~In November 2019, the first instance court accepted the claim of infringement for one of the two patents and the~~The Company ~~has filed an appeal to the Appeals Court Dusseldorf and~~ challenged the validity of both patents. With respect to one of the ~~allegedly infringed patent~~claims, in ~~the German Patent Court. In July~~October 2020, the German Patent Court rendered ~~a preliminary opinion, suggesting that~~ the SMA patent ~~should be revoked in its entirety. Also~~invalid. With respect to the other claim, in November 2019, the first instance court stayed the infringement proceedings ~~regarding the other one of the two patents~~ since it considered it to be highly likely that the second SMA patent would also be rendered invalid. The Company believes that it has meritorious defenses to the claims asserted and intends to vigorously defend against ~~these lawsuits.~~the remaining lawsuit.

In May 2019, the Company was served with three lawsuits by Huawei Technologies Co., Ltd., a Chinese entity (“Huawei”), against the Company's two Chinese subsidiaries and its equipment manufacturer in China. The lawsuits, filed in the Guangzhou intellectual property court, allege infringement of three patents and ask for an injunction of manufacture, use, sale and offer for sale, and damage awards of Chinese yuan (“CNY”) 30 million ~~RMB~~ (approximately $4,250). A first-instance judgment was issued on August 7, 2020 ordering the Company to pay damages in the amount of approximately CNY 10.5 million (approximately $1,550), including court fees, with respect of one of the patents, which was recorded in general and administrative expenses. The Company has filed an appeal with the Supreme People’s Court of China. Following the receipt of the lawsuits, the Company filed three lawsuits in China against Huawei for unauthorized use of patented technology of the Company. These lawsuits are still in process and judgements have not been rendered. The Company believes that it has meritorious defenses to the claims asserted by Huawei and the judgement of the first instance court and intends to vigorously defend against these lawsuits.

In August 2019, the Company was served with a lawsuit by certain former shareholders of S.M.R.E S.p.A (“SMRE”), against its Italian subsidiary that purchased the shares of SMRE in the tender offer which followed the SMRE Acquisition. The shareholders who tendered their shares are asking for the difference between EUR 6 ~~Euro~~ per share, which is the amount they tendered their shares, and EUR 6.77 ~~Euro~~ per share, for a total award of EUR 2.7 million ~~Euros~~ (approximately ~~$3,000)~~$3,150). The Company believes it has meritorious defenses to the claims asserted and intends to vigorously defend against this lawsuit.

In December 2019, the Company received a lawsuit filed by a former consultant of the Company and its Israeli subsidiary in the amount of NIS 25.5 million (approximately ~~$7,350)~~$7,400) claiming damages caused relating to a terminated consulting agreement and stock options therein. The Company believes it has meritorious defenses to the claims asserted and intends to vigorously defend against this lawsuit.

As of September 30, 2020, accrued amounts for legal claims of $1,709, were recorded in accrued expenses and other current liabilities.

Number of shares

Authorized as of

Issued as of

Outstanding as of

Authorized as of

Issued as of

Outstanding as of

June

30, 2020

December

31, 2019

June

30, 2020

December

31, 2019

June

30, 2020

December

31, 2019

September

30, 2020

December

31, 2019

September

30, 2020

December

31, 2019

September

30, 2020

December

31, 2019

Stock of $0.0001 par value:

Common stock

125,000,000

50,075,751

49,081,457

50,075,751

48,898,062

125,000,000

51,207,310

49,081,457

51,207,310

48,898,062

The Company’s 2007 Global Incentive Plan (the “2007 Plan”) was adopted by the board of directors on August 30, 2007. The 2007 Plan terminated upon the Company’s IPO on March 31, 2015 and no further awards may be granted thereunder. All outstanding awards will continue to be governed by their existing terms and 379,358 available options for future grant were transferred to the Company’s 2015 Global Incentive Plan (the “2015 Plan”) and are reserved for future issuances under the 2015 plan.

The 2015 Plan became effective upon the consummation of the IPO. The 2015 Plan provides for the grant of options, RSUs and other share-based awards to directors, employees, officers, and nonemployees of the Company and its Subsidiaries. As of ~~June~~September 30, 2020, a total of 12,828,270 shares of common stock were reserved for issuance under the 2015 Plan (the “Share Reserve”).

The Share Reserve will automatically increase on January 1st of each year during the term of the 2015 Plan, commencing on January 1st of the year following the year in which the 2015 Plan becomes effective, in an amount equal to 5% of the total number of shares of capital stock outstanding on December 31st of the preceding calendar year; provided, however, that the Company’s board of directors may determine that there will not be a January 1st increase in the Share Reserve in a given year or that the increase will be less than 5% of the shares of capital stock outstanding on the preceding December 31st.

The aggregate maximum number of shares of common stock that may be issued on the exercise of incentive stock options is 10,000,000. As of ~~June~~September 30, 2020, an aggregate of 8,627,031 shares of common stock are still available for future grant under the 2015 Plan.

A summary of the activity in the stock options granted to employees and members of the board of directors for the ~~six~~nine months ended ~~June~~September 30, 2020 and related information are as follows:

	Number of Options			Weighted average exercise price		Weighted average remaining contractual term in years		Aggregate intrinsic Value		Number of Options			Weighted average exercise price		Weighted average remaining contractual term in years		Aggregate intrinsic Value

Outstanding as of December 31, 2019		2,112,009			15.44		3.58		168,229		2,112,009			15.44		3.58		168,229
Granted		59,558			101.81						59,558			101.81
Exercised		(568,165	)		9.84						(1,434,129	)		10.93
Outstanding as of June 30, 2020		1,603,402			20.63		3.36		189,447
Outstanding as of September 30, 2020											737,438			31.18		5.79		152,776

Vested and expected to vest as of June 30, 2020		1,597,973			20.43		5.88		189,113
Vested and expected to vest as of September 30, 2020											728,547			31.01		6.85		151,055

Exercisable as of June 30, 2020		1,314,860			15.45		2.32		162,166
Exercisable as of September 30, 2020											497,011			23.48		6.32		106,792

The aggregate intrinsic value represents the total intrinsic value (the difference between the fair value of the Company’s common stock as of the last day of each period and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their options on the last day of each period.

The total intrinsic value of options exercised during the ~~six~~nine months ended ~~June~~September 30, 2020 was ~~$63,632.~~$239,397.

The weighted average grant date fair values of options granted to employees and executive directors during the ~~six~~nine months ended ~~June~~September 30, 2020 was $53.65.

A summary of the activity in the RSUs granted to employees and directors for the ~~six~~nine months ended ~~June~~September 30, 2020 is as follows:

	Number of RSUs			Weighted average grant date fair value		Number of RSUs			Weighted average grant date fair value

Unvested as of December 31, 2019		2,742,589			52.77		2,742,589			52.77
Granted		153,481			88.41		606,666			180.66
Vested		(547,706	)		41.92		(807,986	)		43.34
Forfeited		(107,688	)		54.76		(166,461	)		65.30
Unvested as of June 30, 2020		2,240,676			57.77
Unvested as of September 30, 2020							2,374,808			87.78

The Company adopted an ESPP. As of ~~June~~September 30, 2020, a total of 2,687,451 shares were reserved for issuance under this plan. The number of shares of common stock reserved for issuance under the ESPP will increase automatically on January 1st of each year, for ten years, by the lesser of 1% of the total number of shares of the Company’s common stock outstanding on December 31st of the preceding calendar year or 487,643 shares.

However, the Company’s board of directors may reduce the amount of the increase in any particular year at their discretion, including a reduction to zero.

The ESPP is implemented through an offering every six months. According to the ESPP, eligible employees may use up to 10% of their salaries to purchase common stock shares up to an aggregate limit of $10 per participant for every six months’ plan. The price of an ordinary share purchased under the ESPP is equal to 85% of the lower of the fair market value of the ordinary share on the subscription date of each offering period or on the purchase date.

As of ~~June~~September 30, 2020, 578,778 common stock shares had been purchased under the ESPP.

As of ~~June~~September 30, 2020, 2,108,673 common stock shares were available for future issuance under the ESPP.

In accordance with ASC No. 718, the ESPP is compensatory and as such results in recognition of compensation cost.

d.Stock-based compensation expense for employees and ~~nonemployees:~~non-employees:

The Company recognized stock-based compensation expenses related to stock options, RSUs and PSUs granted to employees and non-employee consultants and ESPP in the condensed consolidated statement of income for the three and ~~six~~nine months ended ~~June~~September 30, 2020 and 2019, as follows:

	Three months ended June 30,				Six months ended June 30,				Three months ended September 30,				Nine months ended September 30,
	2020		2019		2020		2019		2020		2019		2020		2019

Cost of revenues	$	2,359	$	1,651	$	4,632	$	3,005	$	2,730	$	1,691	$	7,362	$	4,696
Research and development		5,847		4,176		11,225		7,666		6,904		4,269		18,129		11,935
Selling and marketing		3,445		2,722		6,637		5,126		4,066		2,779		10,703		7,905
General and administrative		2,310		2,823		4,240		5,279		2,559		2,628		6,799		7,907
Other operating expenses										-		6,242		-		6,242

Total stock-based compensation expense	$	13,961	$	11,372	$	26,734	$	21,076	$	16,259	$	17,609	$	42,993	$	38,685

As of ~~June~~September 30, 2020, there were total unrecognized compensation expenses in the amount of ~~$131,368~~$207,529 related to non‑vested equity‑based compensation arrangements granted under the Company’s Plans. These expenses are expected to be recognized during the period from ~~July~~October 1, 2020 through ~~May~~October 31, 2024.

Basic net Earnings Per Share (“EPS”) is computed by dividing the net earnings attributable to SolarEdge Technologies, Inc. by the weighted-average number of shares of common stock outstanding during the period.

Diluted net EPS is computed by giving effect to all potential shares of common stock, ~~including stock options,~~ to the extent dilutive, including stock options, RSUs, PSUs, shares to be purchased under the Company’s ESPP, and the Notes due 2025, all in accordance with ASC No. 260, "Earnings Per Share."

No shares were excluded from the calculation of diluted net EPS due to their anti-dilutive effect for the three and ~~six~~nine months ended ~~June~~September 30, 2020.

334,096 and ~~289,796~~304,725 shares were excluded from the calculation of diluted net earnings per share due to their anti-dilutive effect for the three and ~~six~~nine months ended ~~June~~September 30, 2019, respectively.

~~The following table presents the computation of basic and diluted net EPS attributable to SolarEdge Technologies, Inc. for the periods presented:~~

Three months ended
June 30,
Six months ended
June 30,
2020
2019
2020
2019

Basic EPS:
Numerator:
Net income
$
36,668
$
32,913
$
78,916
$
50,888
Net loss attributable to Non-controlling interests
-
215
-
1,256
Net income attributable to SolarEdge Technologies, Inc.
$
36,668
$
33,128
$
78,916
$
52,144

Denominator:
Shares used in computing net earnings per share of common stock, basic
49,786,586
47,683,799
49,493,173
47,353,401

Diluted EPS:
Numerator:
Net income
$
36,668
$
32,913
$
78,916
$
50,888
Net loss attributable to Non-controlling interests
-
215
-
1,256
Undistributed earnings reallocated to non-vested
stockholders
-
(220
)
-
(304
)
Net income attributable to SolarEdge Technologies, Inc.
$
36,668
$
32,908
$
78,916
$
51,840

Denominator:
Shares used in computing net earnings per share of common stock, basic
49,786,586
47,683,799
49,493,173
47,353,401
Weighted average effect of dilutive securities:
Non-vested PSU’S
-
(334,096
)
-
(289,796
)
Effect of stock-based awards
2,749,851
2,590,331
2,864,665
2,294,675
Shares used in computing net earnings per share of common stock, diluted
52,536,437
49,940,034
52,357,838
49,358,280

The following table presents the computation of basic and diluted net EPS attributable to SolarEdge Technologies, Inc. for the periods presented:

	Three months ended September 30,					Nine months ended September 30,
	2020		2019			2020		2019

Basic EPS:
Numerator:
Net income	$	43,751	$	41,724		$	122,667	$	92,612
Net (income) loss attributable to Non-controlling interests		-		(97	)		-		1,159
Net income attributable to SolarEdge Technologies, Inc.	$	43,751	$	41,627		$	122,667	$	93,771

Denominator:
Shares used in computing net earnings per share of common stock, basic		50,529,691		48,195,020			49,842,399		47,637,023

Diluted EPS:
Numerator:
Net income	$	43,751	$	41,724		$	122,667	$	92,612
Notes due 2025 (1)		137		-			137		-
Net (income) loss attributable to Non-controlling interests		-		(97	)		-		1,159
Undistributed earnings reallocated to non-vested stockholders		-		(270	)		-		(569	)
Net income attributable to SolarEdge Technologies, Inc.	$	43,888	$	41,357		$	122,804	$	93,202

Denominator:
Shares used in computing net earnings per share of common stock, basic		50,529,691		48,195,020			49,842,399		47,637,023
Weighted average effect of dilutive securities:
Non-vested PSUs		-		(334,096	)		-		(304,725	)
Notes due 2025 (1)		197,984		3,220,670			65,995		2,603,340
Effect of stock-based awards		2,416,513		-			2,715,281		-
Shares used in computing net earnings per share of common stock, diluted		53,144,188		51,081,594			52,623,675		49,935,638

At the time of the acquisition of Kokam Co., Ltd. (“Kokam”), Kokam had an outstanding claim against it for damages. The claim was settled for an amount of $4,900, which was recognized as an expense in other operating expenses in the consolidated statement of income in the year ended December 31, 2019. In March 2020, the Company was indemnified for the full amount by a major selling shareholder of Kokam. ~~The~~For the nine months ended September 30, 2020, the Company recognized this as ~~income in~~ other operating income.

	Three months ended June 30,						Six months ended June 30,						Three months ended September 30,						Nine months ended September 30,
	2020			2019			2020			2019			2020			2019			2020			2019

Current period taxes	$	8,098		$	13,753		$	20,556		$	18,909		$	2,976		$	10,418		$	23,717		$	29,327
Deferred tax income, net and others		(3,236	)		(540	)		(6,772	)		(1,774	)		(568	)		(3,148	)		(7,525	)		(4,922	)

Taxes on income	$	4,862		$	13,213		$	13,784		$	17,135		$	2,408		$	7,270		$	16,192		$	24,405

	June 30,2020		December 31, 2019		September 30, 2020		December 31, 2019

Balance at January 1,	$	8,962	$	8,499	$	9,532	$	8,499
Increases related to current year tax positions		525		463		602		1,033

	$	9,487	$	8,962	$	10,134	$	9,532

Following the completion of three acquisitions during 2018 and 2019, the Company has changed its segments measurement, beginning in 2019. The purpose of the new measurement is to provide the Company’s chief operating decision maker (“CODM”) better information to assess segment performance and to make resource allocation decisions. The Company now operates in five different operating segments: Solar, Critical Power (formerly known as UPS), Energy Storage, e-Mobility and Automation Machines.

The Company's Chief Executive Officer is the CODM who makes resource allocation decisions and assesses performance based on the financial information presented on a consolidated basis, accompanied by disaggregated information about revenues and contributed profit by the operating segments.

Segment profit is comprised of gross profit for the segment less operating expenses that do not include amortization, stock based compensation expenses and certain other items.

The Company manages its assets on a group basis, not by segments, as many of its assets are shared or commingled. The Company’s CODM does not regularly review asset information by segments and, therefore, the Company does not report asset information by segment.

The Company identified one operating segment as reportable – the Solar segment. The other operating segments are insignificant individually and in the aggregate and therefore their results are presented together under “All other”.

The Solar segment includes the design, development, manufacture, and sales of an intelligent inverter solution designed to maximize power generation at the individual PV module level. The solution consists mainly of the Company’s power optimizers, inverters and cloud-based monitoring platform.

The “All other” category includes the design, development, manufacturing and sales of UPS products, energy storage products, e-Mobility products and automated ~~machines for industries.~~machines. Intersegment sales are a source of revenue for one of the operating segments included in the “All other” category.

The Company accounts for intersegment sales as if the sales were to third parties, that is, at current market prices.

The following table presents information on reportable segments profit (loss) for the periods ended September 30, 2020:

The following table presents information on reportable segments profit (loss) for the periods ended September 30, 2019:

~~The following table presents information on reportable segments profit (loss) for the periods ended June 30, 2020:~~

~~The following table presents information on reportable segments profit (loss) for the periods ended June 30, 2019:~~

The following table presents information on reportable segments reconciliation to consolidated revenues for the periods presented:

	Three months ended June 30,					Six months ended June 30,					Three months ended September 30,				Nine months ended September 30,
	2020			2019		2020			2019		2020		2019		2020			2019

Solar segment revenues	$	310,048		$	306,746	$	717,695		$	559,814	$	312,480	$	387,772	$	1,030,175		$	947,586
All other segment revenues		22,290			18,264		45,861			37,067		25,615		22,784		71,476			59,851
Intersegment revenues		(487	)		-		(487	)		-
Adjustment of intersegment revenues												-		-		(487	)		-
Consolidated revenues	$	331,851		$	325,010	$	763,069		$	596,881	$	338,095	$	410,556	$	1,101,164		$	1,007,437

The following table presents information on reportable segments reconciliation to consolidated operating income for the periods presented:

	Three months ended June 30,						Six months ended June 30,						Three months ended September 30,						Nine months ended September 30,
	2020			2019			2020			2019			2020			2019			2020			2019

Solar segment profit	$	54,590		$	66,212		$	142,560		$	111,042		$	56,671		$	89,548		$	199,231		$	200,590
All other segment loss		(7,906	)		(5,174	)		(17,230	)		(8,801	)		(6,627	)		(329	)		(23,857	)		(9,130	)
Segments operating profit		46,684			61,038			125,330			102,241			50,044			89,219			175,374			191,460
Amounts not allocated to segments:
Stock based compensation expenses		(13,961	)		(11,372	)		(26,734	)		(21,076	)		(16,259	)		(11,367	)		(42,993	)		(32,443	)
Amortization		(2,651	)		(3,291	)		(5,336	)		(5,262	)		(2,833	)		(3,409	)		(8,169	)		(8,671	)
Legal settlement (see Note 11)		-			-			4,900			-			-			-			4,900			-
Cost of products adjustments		-			(319	)		(313	)		(1,001	)		-			(107	)		(313	)		(1,108	)
Other unallocated expenses		-			(703	)		-			(1,501	)		(558	)		(14	)		(558	)		(1,515	)
Non recurring expenses														-			(8,305	)		-			(8,305	)
Adjustments:
Intersegment profit		(107	)		-			(107	)		-			-			-			(107	)		-

Consolidated operating income	$	29,965		$	45,353		$	97,740		$	73,401		$	30,394		$	66,017		$	128,134		$	139,418

ITEM 2MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Statements contained in this Form 10-Q or statements incorporated by reference from documents we have filed with the Securities and Exchange Commission may contain forward-looking statements that are based on our management’s expectations, estimates, projections, beliefs and assumptions in accordance with information currently available to our management. Forward-looking statements should be read in conjunction with our unaudited condensed consolidated financial statements and related notes included in Part 1, Item 1 of this report. This discussion contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements include information concerning our possible or assumed future results of operations, business strategies, technology developments, new ~~product development,~~products and services, financing and investment plans, competitive position, industry and regulatory environment, ~~potential~~effects of acquisitions, growth opportunities and the effects of competition. Forward-looking statements include statements that are not historical facts and can be identified by terms such as “anticipate,” “believe,” “could,” “seek,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “will,” “would” or similar expressions and the negatives of those terms.

~~Forward looking~~Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the ~~forward looking~~forward-looking statements. Given these uncertainties, you should not place undue reliance on forward looking statements. Also, ~~forward looking~~forward-looking statements represent our management’s beliefs and assumptions only as of the date of this filing. Important factors that could cause actual results to differ materially from our expectations include:

the duration, scope and effects of the ongoing COVID-19 pandemic, government and other third party responses to it and the related macroeconomic effects, including to our business and the business of our suppliers and customers;

changes to net metering policies or the reduction, elimination or expiration of government subsidies and economic incentives for on‑grid solar energy applications;

changes in the U.S. trade environment, including the imposition of import tariffs;

federal, state and local regulations governing the electric utility industry with respect to solar energy;

the retail price of electricity derived from the utility grid or alternative energy sources;

interest rates and supply of capital in the global financial markets in general and in the solar market specifically;

competition, including introductions of power optimizer, inverter and solar photovoltaic (“PV”) system monitoring products by our competitors;

developments in alternative technologies or improvements in distributed solar energy generation;

our ability to forecast demand for our products accurately and to match production with demand;

our dependence on ocean transportation to deliver our products in a cost effective manner;

our dependence upon a small number of outside contract manufacturers and ~~limited or single source~~ suppliers;

capacity constraints, delivery schedules, manufacturing yields and costs of our contract manufacturers and availability of components;

shortages, delays, price changes or cessation of operations or production affecting our suppliers of key components;

our ability to effectively design, launch, market and sell new generations of our products and services;

our ability to maintain our brand and to protect and defend our intellectual property;

our ability to manage effectively the growth of our organization and expansion into new markets;

~~consolidation in the solar industry among~~ our ~~customers~~ability to service our debt; and ~~distributors; and~~

the other factors set forth under “Item 1A. Risk Factors” in “Part II-OTHER INFORMATION” section of this report.

Except as required by law, we assume no obligation to update these ~~forward‑~~forward looking statements, or to update the reasons actual results could differ materially from those anticipated in these ~~forward‑~~forward looking statements, even if new information becomes available in the future.

We are a leading provider of an optimized inverter solution that has changed the way power is harvested and managed in a solar photovoltaic system, known as PV system. Our direct current or DC optimized inverter system maximizes power generation at the individual PV module level while lowering the cost of energy produced by the solar PV system, for improved return on investment, or RoI. Additional benefits of the DC optimized inverter system include comprehensive and advanced safety features, improved design flexibility, and improved operating and maintenance, or O&M with module-level and remote monitoring. The typical SolarEdge optimized inverter system consists of power optimizers, inverters, a communication device which enables access to a cloud based monitoring platform and in many cases, additional smart energy management solutions. SolarEdge’s solutions addresses a broad range of solar market segments, from residential solar installations to commercial and small utility-scale solar installations.

Since introducing the optimized inverter solution in 2010, SolarEdge has expanded its activity to other areas of smart energy technology, both through organic growth and through acquisitions. SolarEdge now offers energy solutions which include not only residential, commercial and small utility scale PV systems but also product offerings in the areas of energy storage systems, or Energy Storage System or ESS and backup, electric vehicle, or EV components and charging capabilities, home energy management, grid services and virtual power plants, lithium-ion batteries and uninterrupted power supply, known as UPS solutions.

As part of our non-organic growth, we have completed three acquisitions during 2018 and 2019, each of which address our growth in the area of smart energy technology and power optimization.

~~In July 2018, we acquired the assets of a business for the development, manufacturing and sale of UPSs, (“Critical Power Division”).~~

In October 2018, we closed an acquisition of Kokam Co., Ltd. (“Kokam”), a provider of lithium-ion cells, batteries and energy reliable, safe, high-performance storage solutions that is headquartered in South Korea.

During 2019, we completed the acquisition of approximately 99.9% of SolarEdge Automation Machines SPA (“Automation Machines Division”) and SolarEdge eMobility SPA (“e-Mobility Division”) (formerly S.M.R.E Spa and I.E.T Spa, respectively). Our Automation Machines Division manufactures automated machinery for industries and our e-Mobility Division develops end-to-end e-Mobility solutions for electric and hybrid vehicles used in motorcycles and light commercial vehicles. These solutions include integrated, high-performing powertrains with e-motor, motor drive, gearbox, battery, BMS, chargers, vehicle control units and software for electric vehicles.

In September 2020 we commenced the production ramp up of our manufacturing facility in the North of Israel, “Sella 1”. We expect ramp up to continue until the second quarter of 2021 when we expect Sella 1 to reach full manufacturing capabilities.

We are a leader in the global module-level power electronics (“MLPE”) market. As of September 30, 2020, we have shipped approximately 61.7 million power optimizers and 2.6 million inverters. Over 1.75 million installations, many of which may include multiple inverters, are currently connected to, and monitored through, our cloud‑based monitoring platform. As of September 30, 2020, we have shipped approximately 21.0 GW of our DC optimized inverter systems.

Our revenues for the three months ended September 30, 2020 and 2019 were $338.1 million and $410.6 million, respectively. Gross margin was 32.0% and 33.9% for the three months ended September 30, 2020 and 2019, respectively. Net income was $43.8 million and $41.6 million for the three months ended September 30, 2020 and 2019, respectively.

Our revenues for the nine months ended September 30, 2020 and 2019 were $1,101.2 million and $1,007.4 million, respectively. Gross margin was 31.9% and 33.4% for the nine months ended September 30, 2020 and 2019, respectively. Net income was $122.7 million and $93.8 million for the nine months ended September 30, 2020 and 2019, respectively.

We are continuously and closely monitoring the evolving impact of COVID-19 on our operations and business. Our first priority continues to be to protect and support our employees through this period while maintaining company operations and support of our customers with as few disruptions as possible. Given that we have employees in many countries world-wide, we follow the guidance ~~from~~issued by applicable local ~~applicable~~ authorities and health officials in each region in which we do ~~business. In~~business including in our headquarters located in ~~Herziliya,~~ Israel weand have been able to continue ~~partial work~~our operations remotely or from ~~the office throughout the stay at home orders~~our offices. Continued travel restrictions however have had an impact on our operations, including, by way of example delays in third party testing and beginning mid-April, we brought employees who were working from home back to the office, while complying with social distancing orders and in some cases, working in alternating shifts so as to reduce populated office areas.certification of new products. Our manufacturing facilities in Korea and Italy and our contract manufacturers facilities in China, Vietnam and Hungary have remained operational and at almost full capacity, ~~throughout the first quarter and the second quarter of 2020.~~with brief interruptions on a case by case basis in compliance with local laws. Our customer support centers are working at full capacity, primarily from home. Our operations and operating expenses have not been significantly impacted by these adjustments.

As disclosed last quarter, the actions taken around the world to slow the spread of COVID-19 have impacted the installation rate of PV systems which we are closely tracking through our monitoring portal globally and per country. While the COVID-19 pandemic did not have a material adverse impact on our financial results for the first quarter of fiscal 2020, we saw and reported on a decline in installations in certain regions such as the United States and Italy beginning with the outbreak of the COVID-19 pandemic in March, ~~2020. This decline translated into reduced~~2020 and this had a negative impact on our revenues in the second ~~quarter~~and third quarters of 2020 when compared to the first quarter of ~~2020 which were consistent with our guidance in our first quarter earnings release.~~2020. In certain cases we accommodated customers in certain regions who requested to cancel or delay the supply of their orders.

As anticipated, our ~~second~~third quarter revenues of ~~$331.9~~$338.1 million, a ~~decline~~slight increase from ~~$431.2~~reveues of $331.9 million in the ~~prior~~second quarter of 2020, reflect ~~the reduced installations which we reported~~strong installation rates in ~~the first quarter earnings release, primarily~~Europe and rest of world, and slower recovery in the United ~~States, which we attribute to~~States. During the stay at home orders which impacted many installers. While installations rates in the United States continue to be at a rate slightly lower than the same period last year, we have seen a gradual increase of installations since May. Despite Covid-19, installations of SolarEdge PV systems in some European countries continued to increase over the past few months and the result is that our revenues reflect higher sales in certain European countries as compared to the firstthird quarter of ~~2020.~~2020, many of our customers installed systems they had accumulated in inventory, resulting in lower quarterly revenues from our U.S.-based customers.

Our management and board are continuously examining our plans for 2020 and reacting to the current economic downturn, high unemployment rates in many countries and negative impact on businesses generally. As we reported in our Form 10Q for the quarter ended March 31, 2020 and June 30, 2020, we have taken ~~the following~~ actions in order to mitigate the negative impacts of COVID-19 on our business, operating results and financial ~~condition:~~condition. We have reviewed our business plan for 2020 and made certain adjustments in ~~order to accommodate expectations that revenues will be impacted~~the second quarter of 2020 which remained in effect during the ~~forthcoming quarters.~~third quarter. These adjustments include substantial reduction of new hiring that were planned for the third quarter as well as elimination of redundant positions, which reductions were implemented in the past ~~quarter.~~quarters. The impact of these reductions will be reflected in our ~~third quarter~~ 2020 year-end financial results. In addition, as we ~~have carefully scrutinized~~reported last quarter, we reviewed and cut back where possible on our spending and management of operations including a review of all of our variable, ~~expenses in order to identify activities than can be reduced and costs that can be re-negotiated such as consulting and facility related costs. We have also reviewed our~~ research and development projects and ~~prioritized projects with higher revenue potential or infrastructure project over projects with lower expected return. In addition, effective April 1, 2020~~ our ~~senior~~ executives ~~who had already waived their 2020 base salary increases~~and board members also voluntarily reduced their ~~2019~~ base salaries by an additional 20%. Our directors also agreed, effective April 1, 2020 to reduce the cash portion of their compensation by 20% and the Company has temporarily put on hold most plans for expanding its workforce and suspended planned salary increases.salaries/compensation. These measures are reviewed by management on a quarterly basis and to date, remain in place.

We are a leader in the global module-level power electronics (“MLPE”) market. As of June 30, 2020, we have shipped approximately 58.5 million power optimizers and 2.4 million inverters. Over 1.6 million installations, many of which may include multiple inverters, are currently connected to, and monitored through, our cloud‑based monitoring platform. As of June 30, 2020, we have shipped approximately 19.5 GW of our DC optimized inverter systems.

Our revenues for the three months ended June 30, 2020 and 2019 were $331.9 million and $325.0 million, respectively. Gross margin was 31.0% and 34.1% for the three months ended June 30, 2020 and 2019, respectively. Net income was $36.7 million and $33.1 million for the three months ended June 30, 2020 and 2019, respectively.

Our revenues for the six months ended June 30, 2020 and 2019 were $763.1 million and $596.9 million, respectively. Gross margin was 31.8% and 33.0% for the six months ended June 30, 2020 and 2019, respectively. Net income was $78.9 million and $52.1 million for the six months ended June 30, 2020 and 2019, respectively.

In managing our business and assessing financial performance, we supplement the information provided by the financial statements with other operating metrics. These operating metrics are utilized by our management to evaluate our business, measure our performance, identify trends affecting our business and formulate projections. We use metrics relating to shipments (inverters shipped, power optimizers shipped and megawatts shipped) to evaluate our sales performance and to track market acceptance of our products. We use metrics relating to monitoring (systems monitored) to evaluate market acceptance of our products and usage of our solution.

We provide the “megawatts shipped” metric, which is calculated based on nameplate capacity shipped, to show adoption of our PV system on a nameplate capacity basis. Nameplate capacity shipped is the maximum rated power output capacity of an inverter and corresponds to our financial results in that higher total capacities shipped are generally associated with higher total revenues. However, revenues increase with each additional unit, not necessarily each additional MW of capacity, sold. Accordingly, we also provide the “inverters shipped” and “power optimizers shipped” operating metrics.

	Three Months Ended June 30,				Six Months Ended June 30,				Three Months Ended September 30,				Nine Months Ended September 30,
	2020		2019		2020		2019		2020		2019		2020		2019
Inverters shipped		141,689		160,117		343,698		290,789		152,531		187,887		496,229		478,676
Power optimizers shipped		3,515,906		3,730,519		8,576,297		6,759,621		3,271,787		4,587,380		11,848,084		11,347,001
Megawatts shipped (1)		1,442		1,335		3,292		2,479		1,451		1,498		4,743		3,977

The results of operations presented below should be reviewed in conjunction with the condensed consolidated financial statements and related notes included elsewhere in this report.

The following table sets forth selected consolidated statements of income data for each of the periods indicated.

	Three Months Ended June 30,						Six Months Ended June 30,					Three Months Ended September 30,						Nine Months Ended September 30,
	2020			2019			2020			2019		2020			2019			2020			2019
	(In thousands)						(In thousands)					(in thousands)						(in thousands)
Revenues	$	331,851		$	325,010		$	763,069		$	596,881	$	338,095		$	410,556		$	1,101,164		$	1,007,437
Cost of revenues		228,888			214,340			520,098			400,101		230,032			271,247			750,130			671,348
Gross profit		102,963			110,670			242,971			196,780		108,063			139,309			351,034			336,089
Operating expenses:
Research and development		38,098			29,505			74,793			55,704		40,817			30,747			115,610			86,451
Sales and marketing		20,936			22,127			45,189			42,299		21,924			22,026			67,113			64,325
General and administrative		13,964			13,685			30,149			25,376		14,928			12,214			45,077			37,590
Other operating income		-			-			(4,900	)		-
Other operating expenses (income)													-			8,305			(4,900	)		8,305
Total operating expenses		72,998			65,317			145,231			123,379		77,669			73,292			222,900			196,671
Operating income		29,965			45,353			97,740			73,401		30,394			66,017			128,134			139,418
Financial expenses (income), net		(11,565	)		(773	)		5,040			5,378		(15,765	)		17,023			(10,725	)		22,401
Income before taxes on income		41,530			46,126			92,700			68,023		46,159			48,994			138,859			117,017
Taxes on income		4,862			13,213			13,784			17,135		2,408			7,270			16,192			24,405
Net income	$	36,668		$	32,913		$	78,916		$	50,888	$	43,751		$	41,724		$	122,667		$	92,612
Net loss attributable to non-controlling interests		-			215			-			1,256
Net loss (gain) attributable to non-controlling interests													-			(97	)		-			1,159
Net income attributable to SolarEdge Technologies, Inc.	$	36,668		$	33,128		$	78,916		$	52,144	$	43,751		$	41,627		$	122,667		$	93,771

Revenues ~~increased~~decreased by ~~$6.8~~$72.5 million, or ~~2.1%~~17.6%, for the three months ended ~~June~~September 30, 2020 as compared to the three months ended ~~June~~September 30, 2019, primarily due to ~~increased~~decreased sales ~~in Europe and to a lesser extent, price increases on products sold~~ in the U.S. ~~intended~~which we attribute principally to ~~offset~~ the ~~increase in imposed tariffs on China-made products effective June 1, 2019.~~

Similar to the same quarter last year, revenues from outside of the U.S. comprised 62.0% of our revenues for the three months ended June 30, 2020 compared to 61.6% for the three months ended June 30, 2019.

~~Given the continued~~ adverse effect of the COVID 19 pandemic on the economy in the United ~~States which led~~States. This decrease was partially offset by $18.5 million of increased sales in Europe and the rest of world. Revenues from outside of the U.S. comprised 68.4% of our revenues for the three months ended September 30, 2020 compared to ~~reduced installations,~~51.8% for the three months ended September 30, 2019.

In our solar business, we expect that ~~our third~~in the fourth quarter of 2020, revenues from Europe will decrease due to seasonality which is typically experienced in Europe during the ~~U.S.~~colder months. This reduction is expected to be offset by higher anticipated revenues in the United States which we expect will ~~be lower than~~result in a slight increase in the overall revenues in the fourth quarter of 2020 as compared to the third quarter of ~~2019 while we expect continued strength in~~2020. It is also expected that the fourth quarter results will include revenues from ~~Europe and rest~~the sale of ~~world.~~full powertrain kits to an automative OEM by our eMobility business which is part of our non-solar business.

The number of power optimizers recognized as revenues ~~increased~~decreased by approximately ~~115,500~~1.3 million units, or ~~3.2%~~28.3%, from approximately ~~3.6~~4.6 million units in the three months ended ~~June~~September 30, 2019 to approximately ~~3.7~~3.3 million units in the three months ended ~~June~~September 30, 2020. The number of inverters recognized as revenues decreased by approximately ~~17,600~~30,800 units, or ~~11.0%~~16.5%, from approximately ~~159,300~~187,000 units in the three months ended ~~June~~September 30, 2019 to approximately ~~141,700~~156,200 units in the three months ended ~~June~~September 30, 2020. Our blended ASP per watt for solar products shipped decreased by ~~$0.027,~~$0.049, or ~~11.3%~~18.5%, in the three months ended ~~June~~September 30, 2020 as compared to the three months ended ~~June~~September 30, 2019. This reduction is primarily attributed to an increased rate of revenues driven from the sale of commercial products mainly in the U.S that are characterized with lower ASP per watt as well as a ~~higher rate of revenues driven from outside~~change in our customer mix in the United States towards larger customers that ~~are usually characterized by lower ASP due to a more competitive marketplace, and the devaluation of foreign currencies compared to the U.S. dollar.~~enjoy preferable pricing. This ASP erosion was partially offset by ~~increased prices in~~the strengthening of the Euro against the U.S. ~~intended to offset the increase in imposed tariffs on China-made products beginning in June 2019.~~dollar.

	Three Months Ended June 30,				Three Months Ended June 30, 2019 to 2020					Three Months Ended September 30,				Three Months Ended September 30, 2019 to 2020
	2020		2019		Change					2020		2019		Change
	(in thousands)									(in thousands)
Cost of revenues	$	228,888	$	214,340	$	14,548		6.8	%	$	230,032	$	271,247	$	(41,215	)	(15.2	)%
Gross profit	$	102,963	$	110,670	$	(7,707	)	(7.0	)%	$	108,063	$	139,309	$	(31,246	)	(22.4	)%

Cost of revenues ~~increased~~decreased by ~~$14.5~~$41.2 million, or ~~6.8%~~15.2%, in the three months ended ~~June~~September 30, 2020, as compared to the three months ended ~~June~~September 30, 2019, primarily due to:

~~an increase~~a decrease in the volume of $8.7 million in other production costs, which include an accrual for possible raw material write offs resulting from our reduced manufacturing forecast (triggered by lower demand) which may result in rendering these raw materials obsolete as well as other expenses related to reduced manufacturing volumes due to COVID-19;products sold;

~~Increased~~decreased shipment and logistics costs of ~~$5.0~~$16.0 million mainly attributed to ~~the change in~~lower custom tariff ~~rates~~charges on Chinese made products imported into the U.S resulting from a decrease in sales in the U.S and a higher portion of our products manufactured outside of China that were imported into the U.S. ~~from 10% to 25% in June 2019 offset by~~In addition, a decrease in air shipment ~~expenses which was enabled due to~~costs resulted from higher inventory levels. ~~High inventory levels were a result of lower demand coupled with sufficient manufacturing capacity.~~

~~increased personnel-related costs of $2.9 million related to the expansion of our operations and support headcount which grew in parallel to our growing install base worldwide; and~~

~~These increases were partially offset by~~ a decrease in warranty expenses and warranty accruals of ~~$3.2~~$6.6 million associated with various cost reductions on the different elements of our warranty expenses which include the cost of the products, shipment and other related ~~expenses.~~expenses;

These decreases were partially offset by an increase of $8.1 million in other production costs, which were mainly attributed to:

$1.3 million related to ramp up costs associated with the commencement of production in the Sella 1 manufacturing facility; and

$2.9 million related to ramp up manufacturing expenses in the SolarEdge e-Mobility division.

In our solar business we anticipate that our cost of revenues per unit will ~~remain similar~~decrease in the ~~third~~last quarter of 2020 ~~given our outlook for similar geographic and product mix.~~due to realization of cost reduction activities conducted in the previous quarters.

Gross profit as a percentage of revenue decreased from ~~34.1%~~33.9% in the three months ended ~~June~~September 30, 2019 to ~~31.0%~~32.0% in the three months ended ~~June~~September 30, 2020, primarily due to:

~~increased shipment and logistics costs resulting from increased customs tariffs~~a decrease in the ~~U.S;~~volume of products sold;

~~lower gross profit~~increased rate of actual support costs related to our warranty obligations due to an increase in our install base from past sales which effects the calculation of such costs as a percentage of our ~~Critical Power, e-Mobility and Automation Machines Divisions;~~revenues since our install base grew in 2020 while revenues decreased compared to the same quarter of 2019, resulting in a higher rate of warranty expenses to revenues.

an increase in other production costs and inventory valuation accruals as well as other expenses related to reduced manufacturing volumes due to COVID-19;

the arithmetic effect from the increase in selling prices in the U.S. intended to offset the increase in tariffs on Chinese made products and the same increase in cost of goods sold as a result of the increased tariffs; and

~~increased actual support costs related to~~lower gross profit from our ~~warranty obligations.~~e-Mobility and Automation Machines divisions, coupled with ramp up manufacturing expenses in our e-Mobility division.

~~increased profit~~decreased shipment and logistics costs mainly attributed to lower custom tariff charges on Chinese made products imported into the U.S resulting from ~~units sold due to~~ a ~~combination of stable selling prices and cost reductions~~decrease in sales in the ~~manufacturing process~~U.S and a higher portion of ~~such products;~~our products manufactured outside of China that were imported into the U.S.

In addition, a decrease in air shipments costs resulted from higher inventory levels; and

decreased warranty accruals due to various cost reductions on the different elements of our warranty expenses which include the cost of the products, shipment and other related ~~expenses.~~expenses and a change in the product mix sold in the third quarter of 2020 compared to the same period in the previous year.

We expect that gross margin as a percent of revenues will remain ~~stable~~similar in the fourth quarter of 2020 to that of the third quarter of 2020 as a result of factors related to the impacts of COVID-19 and due to expectation of a similar geographic and product mix of our revenues which will be inclined towards Europe and rest of the world.2020.

In light of the uncertain impact of COVID-19 on the rate of growth of our ~~newly~~ acquired businesses, accounting estimates and assumptions related to goodwill, intangible and other assets may change over time in response to uncertain circumstances related to this evolving situation. Such changes could result in future impairments of goodwill, intangible and other assets.

Research and development ~~expenses~~costs increased by ~~$8.6~~$10.1 million, or ~~29.1%~~32.8%, in the three months ended ~~June~~September 30, 2020, as compared to the three months ended ~~June~~September 30, 2019, primarily due to:

an increase in personnel-related costs of ~~$5.5~~$7.7 million resulting from an increase in our research and development headcount as well as salary expenses associated with employee equity-based compensation. The increase in headcount reflects anour continuing investment in enhancements of existing products ~~and~~as well as research and development expenses associated with bringing new products to the market; ~~and~~

increased expenses related to consultants and ~~sub-contractors~~sub‑contractors in an amount of ~~$2.2 million.~~$1.1 million;

We expect that our research and development expenses in the ~~third~~fourth quarter will remain ~~similar~~relatively stable compared to the ~~second~~third quarter primarily due to cost reduction activities initiated in response to COVID-19 and the continued ~~virtual~~ halt in travel and travel related expenses.

Sales and marketing expenses decreased by ~~$1.2~~$0.1 million, or ~~5.4%~~0.5%, in the three months ended ~~June~~September 30, 2020, as compared to the three months ended ~~June~~September 30, ~~2019, primarily due to:~~

expenses related to marketing activities that decreased by $1.3 million due to the cancellation or postponement of marketing activities, exhibitions and shows, which changes were triggered by COVID-19; and

~~expenses related to travel decreased by $ 1.2 million, also as a result of Covid-19.~~

increased personnel-related costs of $0.6 million as a result of an increase in headcount supporting our growth in the U.S., Europe and Asia, as well as salary expenses associated with employee equity-based compensation; and

~~increased consultants and sub-contractors expenses, other overhead and amortization costs of $0.8 million.~~2019.

We expect sales and marketing expenses to ~~continue to be at a similar level~~slightly increase in the ~~third~~fourth quarter of 2020 primarily due to ~~cancellation of~~an increase in our sales and marketing ~~events,~~headcount. This increase is expected to be partially offset by our cost reduction activities initiated in response to COVID-19 and the reduction of expenses related to the continued halt in travel and travel related expenses.

General and administrative expenses increased by ~~$0.3~~$2.7 million, or ~~2.0%~~22.2%, in the three months ended ~~June~~September 30, 2020, as compared to the three months ended ~~June~~September 30, ~~2019.~~2019, primarily due to:

increased expenses related to consultants and sub‑contractors in an amount of $2.0 million, which includes a $1.5 million provision resulting from a litigation judgement in China that is under appeal; and

increased personnel-related costs of $1.3 million resulting from an increase in headcount supporting our growth in Europe and Asia, as well as salary expenses associated with employee equity-based compensation.

While we did provide payment extensions to certain customers, ~~most~~substantially all of these payments have now been made and we did not experience significant customer defaults on payments or incur substantial losses related to customer bankruptcies. We continue to be cautious in ~~the way we provide~~providing credit to our customers. In the ~~third~~fourth quarter of 2020, we may still incur customer defaults on payments and other bad debts as a result of the impact of the economic downturn caused by COVID-19 on our customers. If ~~that happens,~~this occurs, these write-offs would be reflected in our general and administrative expenses in future fiscal quarters.

Other operating expenses decreased by $8.3 million, in the three months ended September 30, 2020 compared to the three months ended September 30, 2019, due to expenses in the amount of $8.3 million related to payroll, bonus and employees’ equity-based compensation acceleration related to the untimely death of Mr. Guy Sella, our Founder, who had served as CEO and Chairman of the Board of Directors until shortly before his passing.

Financial income was ~~$11.6~~$15.8 million in the three months ended ~~June~~September 30, 2020 compared to financial ~~income~~expenses of ~~$0.8~~$17.0 million in the three months ended ~~June~~September 30, 2019, primarily due to an increase of ~~$11.3~~$18.9 million in financial income resulted from foreign exchange fluctuations, mainly between each of the Euro, the New Israeli Shekel, the Australian Dollar and the South Korean Won against the U.S. ~~Dollar.~~Dollar, compared to financial expenses of $15.8 million in the three months ended September 30, 2019.

Taxes on income decreased by ~~$8.4~~$4.9 million, or ~~63.2%~~66.9%, in the three months ended ~~June~~September 30, 2020 as compared to the three months ended ~~June~~September 30, 2019, primarily due to:

a decrease of ~~$4.6~~$7.3 million of current tax expenses ~~related~~mainly attributed to a decrease in taxable income and GILTI taxes, both due to higher deductible expenses in the three months ended September 30, 2020, as compared to the ~~decrease of income before taxes, worldwide;~~three months ended September 30, 2019; and

This decrease was partially offset by a decrease of $3.7 million in deferred tax assets, ~~(presented as tax benefit), net~~net.

Given the ongoing impact of the economic downturn caused by COVID-19, we expect our ~~profitability to decrease in the coming quarters. Such decrease will likely result in a decrease in our~~ tax expenses related to taxes on ~~income.~~income to remain stable.

As a result of the factors discussed above, net income increased by ~~$3.8~~$2.0 million, or ~~11.4%~~4.9%, in the three months ended ~~June~~September 30, 2020, as compared to the three months ended ~~June~~September 30, 2019.

Revenues increased by ~~$166.2~~$93.7 million, or ~~27.8%~~9.3%, for the ~~six~~nine months ended ~~June~~September 30, 2020 as compared to the ~~six~~nine months ended ~~June~~September 30, 2019, primarily due to (i) an increase in the number of inverters and power optimizers sold, with ~~significant~~ growth in revenues coming from Europe and from the U.S., mainly during the first quarter of 2020; and (ii) price increases on products sold in the U.S. intended to offset the increase in imposed tariffs on China made products in June 2019. Revenues from outside of the U.S. comprised ~~51.0%~~56.4% of our revenues for the ~~six~~nine months ended ~~June~~September 30, 2020 compared to ~~59.2%~~56.2% for the ~~six~~nine months ended ~~June~~September 30, 2019. The number of power optimizers recognized as revenues increased by approximately ~~1.9~~0.6 million units, or ~~28.2%~~5.2%, from approximately ~~6.6~~11.2 million units in the ~~six~~nine months ended ~~June~~September 30, 2019 to approximately ~~8.5~~11.8 million units in the ~~six~~nine months ended ~~June~~September 30, 2020. The number of inverters recognized as revenues increased by approximately ~~47,400~~16,600 units, or ~~16.3%~~3.5%, from approximately ~~291,400~~478,400 units in the ~~six~~nine months ended ~~June~~September 30, 2019 to approximately ~~338,800~~495,000 units in the ~~six~~nine months ended ~~June~~September 30, 2020. ~~However, the devaluation of foreign currencies compared to the U.S. Dollar, negatively impacted our U.S. Dollar denominated ASP. In addition, revenues~~Revenues from sale of commercial products that are characterized with lower ASP per watt increased during the ~~six~~nine months ended ~~June~~September 30, 2020 as compared to the ~~six~~nine months ended ~~June~~September 30, 2019. Overall, and primarily due to the factors detailed above, our ASP per watt for ~~for~~ solar products shipped decreased by ~~$0.009,~~$0.024, or ~~4.0%~~9.7%, in the ~~six~~nine months ended ~~June~~September 30, 2020 as compared to the ~~six~~nine months ended ~~June~~September 30, 2019.

	Six Months Ended June 30,				Six Months Ended June 30, 2019 to 2020				Nine Months Ended September 30,				Nine Months Ended September 30, 2019 to 2020
	2020		2019		Change				2020		2019		Change
	(In thousands)								(in thousands)
Cost of revenues	$	520,098	$	400,101	$	119,997	30.0	%	$	750,130	$	671,348	$	78,782	11.7	%
Gross profit	$	242,971	$	196,780	$	46,191	23.5	%	$	351,034	$	336,089	$	14,945	4.4	%

Cost of revenues increased by ~~$120.0~~$78.8 million, or ~~30.0%~~11.7%, in the ~~six~~nine months ended ~~June~~September 30, 2020, as compared to the ~~six~~nine months ended ~~June~~September 30, 2019, primarily due to:

increased customs tariffs, shipment and logistics costs of ~~$32.8~~$16.9 million attributed to the change in tariff rates on Chinese made products imported into the U.S. from 10% to 25% in June 2019 as well as an increase in shipment costs due to increased product ~~demand.~~demand mainly in the first quarter of 2020;

an increase in other production costs of ~~$17.3,~~$26.4 million, which ~~include~~is mainly attributed to: an accrual for possible raw material write offs resulting from our reduced manufacturing forecast (triggered by lower demand) which may result in rendering these raw materials obsolete as well as other expenses related to reduced manufacturing volumes due to ~~COVID-19;~~COVID-19. In addition this amount includes $1.3 million related to ramp up costs associated with the commencement of production in the Sella 1 manufacturing facility and $2.9 million related to ramp up manufacturing expenses in our e-Mobility division; and

an increase in personnel-related costs of ~~$7.0~~$7.5 million related to the expansion of our operations and support headcount which grew in parallel to our growing install base worldwide and in connection with entering into the machinery and integrated powertrain markets.

This increase was partially offset by a decrease in warranty expenses and warranty accruals of $5.4 million associated with various cost reductions on the different elements of our warranty expenses which include the cost of the products, shipment and other related expenses;

Gross profit as a percentage of revenue decreased from ~~33.0%~~33.4% in the ~~six~~nine months ended ~~June~~September 30, 2019 to ~~31.8%~~31.9% in the ~~six~~nine months ended ~~June~~September 30, 2020, primarily due to:

increased shipment and logistics costs resulted from our growth and new customs tariff rules in the U.S. ~~and an increase in air shipments during the first quarter of 2020;~~;

the arithmetic effect from the increase in selling prices in the U.S. intended to offset the increase in tariffs on Chinese made products imported into the U.S. from 10% to 25% in June 2019;

lower gross profit from our ~~Critical Power,~~ e-Mobility and ~~Automated~~Automation Machines ~~Divisions;~~Divisions, coupled with ramp up manufacturing expenses in our e-Mobility division.

~~general economies of scale in our personnel-related costs and other costs associated with our support and operations departments;~~

increased profit on ~~the~~ units sold due to ~~a combination of stable selling prices and~~ cost reductions in the manufacturing process of these products; and

decreased warranty accruals due to various cost reductions on the different elements of our warranty expenses which include the cost of the products, shipment and other related expenses.

Research and development increased by ~~$19.1~~$29.2 million, or ~~34.3%~~33.7%, in the ~~six~~nine months ended ~~June~~September 30, 2020, as compared to the ~~six~~nine months ended ~~June~~September 30, 2019, primarily due to:

an increase in personnel-related costs of ~~$13.8~~$21.5 million resulting from an increase in our research and development headcount as well as salary expenses associated with employee equity-based compensation. The increase in headcount reflects anour continued investment in enhancements of existing products and research and development expenses associated with bringing new products to the market;

increased expenses related to consultants and sub-contractors in an amount of ~~$2.3~~$3.4 million; and

increased expenses related to other overhead costs in an amount of ~~$1.9~~$2.9 million.

Sales and marketing expenses increased by ~~$2.9~~$2.8 million, or ~~6.8%~~4.3%, in the ~~six~~nine months ended ~~June~~September 30, 2020 as compared to the ~~six~~nine months ended ~~June~~September 30, 2019, primarily due to:

increased personnel-related costs of ~~$4.5~~$5.8 million as a result of an increase in headcount supporting our growth, ~~in the U.S., Europe and Asia,~~ as well as salary expenses associated with employee equity-based compensation; and

increased expenses related to other overhead costs and other expenses in an amount of ~~$0.9~~$1.2 million.

decreased expenses related to marketing activities in an amount of ~~$1.5~~$2.1 million; and

General and administrative expenses increased by ~~$4.8~~$7.5 million, or ~~18.8%~~19.9%, in the ~~six~~nine months ended ~~June~~September 30, 2020 as compared to the ~~six~~nine months ended ~~June~~September 30, 2019, primarily due to to:

increased expenses related to an accrual for doubtful debts in an amount of ~~$3.7~~$3.9 million; and

Other operating income ~~increased by~~was $4.9 million, in the ~~six~~nine months ended ~~June~~September 30, 2020 compared to other operating expenses of $8.3 million in the ~~six~~nine months ended ~~June~~September 30, 2019, due ~~to the~~to:

a payment ~~to us out of escrow~~ of $5 million ~~relating~~received by us in connection to a matter settled in arbitration for Kokam Co., Ltd. (“Kokam”) in the fourth quarter of 2019, for which we had ~~indemnification.~~indemnification; and

a decrease in expenses in the amount of $8.3 million related to payroll, bonus and employees’ equity-based compensation acceleration related to the untimely death of Mr. Guy Sella, our Founder, who had served as CEO and Chairman of the Board of Directors until shortly before his passing.

Financial ~~expenses slightly decreased by $0.3~~income was $10.7 million ~~or 6.3%~~ in the ~~six~~nine months ended ~~June~~September 30, 2020 compared to financial expenses of $22.4 million in the ~~six~~nine months ended ~~June 30, 2019, primarily due to:~~

an increase of $1.7 million related to income in foreign exchange fluctuations of lease agreement liabilities as part of the adoption of Accounting Standards Update No. 2016-02, (Topic 842) "Leases; and

~~an increase of $0.5 million in finance income related to hedging transactions.~~

~~These factors were partially offset by an increase of $1.7 million in other financial expenses and bank charges.~~

~~Taxes on income decreased by $3.4 million, or 19.6% in the six months ended June 30, 2020 compared to the six months ended June~~September 30, 2019, primarily due to an increase of ~~$4.8~~$34.7 million in foreign exchange fluctuations, mainly between each of the Euro, the New Israeli Shekel, the Australian Dollar and the South Korean Won against the U.S. Dollar.

Taxes on income decreased by $8.2 million, or 33.7% in the nine months ended September 30, 2020 compared to the nine months ended September 30, 2019, primarily due to:

a decrease of $5.5 million of current tax expenses mainly attributed to a decrease of taxable income and GILTI taxes, both due to higher deductible expenses in the nine months ended September 30, 2020, as compared to the nine months ended September 30, 2019.

an increase of $1.0 million in deferred tax assets, ~~(presented as tax benefit),~~ net. ~~This increase was partially offset by an increase of $2.2 million in current tax expenses, net, mainly related to an increase in profit before Tax;~~

As a result of the factors discussed above, net income increased by ~~$28.0~~$30.1 million, or ~~55.1%~~32.5% in the ~~six~~nine months ended ~~June~~September 30, 2020, as compared to the ~~six~~nine months ended ~~June~~September 30, 2019.

The following table shows our cash flow from operating activities, investing activities and financing activities for the stated periods:

	Three Months Ended June 30,					Six Months Ended June 30,					Three Months Ended September 30,						Nine Months Ended September 30,
	2020		2019			2020		2019			2020			2019			2020		2019
	(In thousands)										(In thousands)
Net cash provided by operating activities	$	59,310	$	50,784		$	167,055	$	107,234		$	28,374		$	68,700		$	195,429	$	175,934
Net cash provided by (used in) investing activities	$	46,800	$	(35,176	)	$	26,876	$	(52,221	)	$	(26,177	)	$	(6,176	)	$	699	$	(58,397	)
Net cash provided by (used in) financing activities	$	5,681	$	(64,755	)	$	8,996	$	(67,385	)	$	628,317		$	(922	)	$	637.313	$	(68,307	)
Increase (decrease) in cash and cash equivalents	$	111,791	$	(49,147	)	$	202,927	$	(12,372	)
Increase in cash and cash equivalents											$	630,514		$	61,602		$	833,441	$	49,230

As of ~~June~~September 30, 2020, our cash and cash equivalents were ~~$428.4~~$1,048.1 million. This amount does not include ~~$158.7~~$131.6 million invested in available for sale marketable securities, ~~$2.1~~$2.2 million invested in restricted bank deposits and ~~$3.4~~$20.0 million invested in short-term bank deposits. Our principal uses of cash are funding our operations and other working capital requirements. As of ~~June~~September 30, 2020, we have open commitments for capital expenditures in an amount of approximately ~~$80.3~~$114.5 million. These commitments reflect purchases of automated assembly lines and other machinery related to our manufacturing operations. We also have purchase obligations in the amount of $326.7 million related to raw materials and commitments for the future manufacturing of our products. We believe that cash provided by operating activities as well as our cash and cash equivalents will be sufficient to meet our anticipated cash needs for at least the next 12 months including the self-funding of our capital expenditure commitments.

To the extent that revenues decrease over the coming ~~few~~ quarters due to the economic downturn caused by ~~the global pandemic,~~COVID-19, we expect that our cash balances ~~will~~would also decrease. This will be compounded by our continued investment in research and development activities including the establishment of a lithium-ion factory in Korea which is continuing as planned and the support of our other non-solar businesses as they grow. We carefully oversee our cash resources and believe that our strong balance sheet positions us well to manage the coming quarters despite any temporary decline in revenues.

On March 27, 2020, the Coronavirus Aid, Relief and Economic Security (“CARES”) Act was enacted and signed into law. Section 2302 of the CARES Act provides that employers may defer the deposit and payment of the employer's portion of Social Security taxes imposed under section 3111(a) of the Internal Revenue Code. As permitted under the CARES Act, we deferred payment of social security taxes through the end of 2020 (with 50% of the deferred amount due December 31, 2021 and the remaining of 50% amount due December 31, 2022). This deferral is expected to provide approximately $1.2 million in additional liquidity during 2020.

For the ~~six~~nine months ended ~~June~~September 30, 2020, cash provided by operating activities was ~~$167.1~~$195.4 million, derived mainly from net income of ~~$78.9~~$122.7 million that included ~~$35.9~~$62.2 million of non-cash expenses, a decrease of ~~$116.0~~$118.0 million in trade receivables and ~~$37.1~~$37.9 million in prepaid expenses and other accounts receivable, an increase of ~~$5.8~~$10.6 million in accrued expenses and other accounts payable, ~~$20.2~~$23.2 million in warranty obligations, and ~~$1.5~~$3.1 million accruals for employees. This was offset by a decrease of ~~$31.8~~$24.3 million in deferred revenues, ~~$1.8~~$35.5 million in trade payables, an increase of ~~$94.2~~$122.0 million in inventories, and $0.5 million in operating lease liabilities.

For the ~~six~~nine months ended ~~June~~September 30, 2019, cash provided by operating activities was ~~$107.2~~$175.9 million, derived mainly from a net income of ~~$50.9~~$92.6 million that included ~~$32.8~~$54.5 million of non-cash expenses, an increase of ~~$28.9~~$49.6 million in warranty obligations, ~~$28.2~~$39.6 million in accrued expenses and other accounts payable, ~~$11.8~~$21.3 million in trade payables, $19.5 million of deferred revenues, ~~$5.5 million in trade payables, $5.1~~$15.3 million in accruals for employees, ~~$1.5~~$2.1 in operating lease liabilities and a$15.8 million decrease ~~of $1.7 million~~ in inventories, which were offset by an increase of ~~$56.6~~$114.6 million in trade receivables, net, and ~~$2.6~~$19.8 million in prepaid expenses and other ~~assets.~~receivables.

As a result of the ~~economic downturn triggered~~disruption caused by COVID-19, we ~~expect~~continue to anticipate a lower volume of orders in the ~~second half of 2020~~next quarters relative to pre-COVID-19 orders, and in light of purchase obligations and manufacturing commitments incurred by us prior to the outbreak of COVID-19, our inventory levels may further increase in the ~~second half of 2020~~next quarters resulting in consumption of cash for operating activities.

During the ~~six~~nine months ended ~~June~~September 30, 2020 net cash provided by investing activities was ~~$26.9~~$0.7 million, of which ~~$89.7~~$116.4 million from ~~sales and~~ maturities of available-for-sale marketable securities which ~~we sold~~were not re-invested in order to maintain high cash balances to mitigate risks associated with COVID-19 ~~$25.6~~and $25.5 million from the withdrawal from restricted bank ~~deposits and $2.1 million related to other investing activities.~~deposits. This was offset by $36.8 million which was invested in available-for-sale marketable securities, $14.6 million was invested in short term bank deposits, and ~~$53.7~~$89.8 million was related to capital investments in laboratory equipment, end of line testing equipment, automated assembly lines, manufacturing tools and leasehold improvements.

During the ~~six~~nine months ended ~~June~~September 30, 2019, net cash used in investing activities was ~~$52.2~~$58.4 million, of which ~~$63.7~~$103.7 million was invested in available-for-sale marketable securities, ~~$38.4~~$39.7 million ~~was utilized for the SMRE acquisition and $22.2 million was~~ related to capital investments in laboratory equipment, end of line testing equipment, automated assembly lines, manufacturing tools and leasehold ~~improvements.~~improvements, net, $38.4 million was utilized for the acquisition of SolarEdge Automation Machines SPA and SolarEdge eMobility SPA (formerly S.M.R.E Spa and I.E.T Spa, respectively), This was offset by ~~$68.4~~$119.6 million from proceeds from sales and the maturities of available-for-sale marketable securities and a decrease of ~~$3.7~~$3.8 million in bank deposits.

For the ~~six~~nine months ended ~~June~~September 30, 2020, net cash provided by financing activities was ~~$9.0~~$637.3 million, of which, $618.3 million were proceeds from the issuance of the Notes, net of $14.2 million of issuance costs , $15.2 million related to proceeds from new bank loans of Kokam and ~~$9.1~~$19.2 million attributed to cash received from the exercise of employee and non-employee stock-based awards. This was offset by ~~$15.2~~$15.4 million used for repayment of loans we acquired as part of the Kokam ~~Acquisition and $0.1 million, which was related to other financing activities.~~acquisition.

For the ~~six~~nine months ended ~~June~~September 30, 2019, net cash used in financing activities was ~~$67.4~~$68.3 million, of which ~~$66.5~~$67.1 million ~~was~~ related to the purchase of non-controlling interests in Kokam and ~~SMRE and $4.7~~SolarEdge Automation Machines, $4.9 million was used for repayment of loan obligations we acquired as part of the acquisitions of Kokam, SolarEdge Automation Machines SPA and ~~SMRE Acquisitions.~~SolarEdge eMobility SPA and $1.2 million was related to the purchase of land and building formerly leased under a financial lease. This was offset by ~~$3.8~~$4.9 million attributed to cash received from the exercise of employee and non-employee stock options.

On September 25, 2020, we issued $632.5 million aggregate principal amount of our Notes in a transaction exempt from registration pursuant to Rule 144A and Regulation S under the Securities Act. Net proceeds from the offering, after underwriters’ discount and commissions and offering expenses, was $617.9 million. We intend to use the proceeds of the Notes for general corporate purposes. See Note 8 to our interim financial statements for more information.

During the ~~six~~nine months ended ~~June~~September 30, 2020, Kokam redeemed all outstanding loans and entered into new bank loans in an aggregate amount of ~~$15.3~~$15.2 million. The new bank loans mature in two installments through December 31, 2020, with annual interest rate of 1.64%. As of ~~June~~September 30, 2020, the aggregate outstanding amount of the new bank loans was ~~$15.2~~$15.6 million.

We are exposed to market risk in the ordinary course of our business. Market risk represents the risk of loss that may impact our financial position due to adverse changes in financial market prices and rates. Our market risk exposure is primarily a result of fluctuations in foreign currency exchange rates, customer concentrations and interest rates. We do not hold or issue financial instruments for trading purposes.

Approximately ~~45.6%~~50.7% and ~~54.8%~~52.3% of our revenues for the ~~six~~nine months ended ~~June~~September 30, 2020 and 2019, respectively, were earned in non‑U.S. Dollar denominated currencies, principally the Euro. Our expenses are generally denominated in the currencies in which our operations are located, primarily the U.S. Dollar and New Israeli Shekel, and to a lesser extent, the Euro and Korean Won. Our New Israeli Shekel‑denominated expenses consist primarily of personnel and overhead costs. Our consolidated results of operations and cash flows are, therefore, subject to fluctuations due to changes in foreign currency exchange rates and may be adversely affected in the future due to changes in foreign exchange rates. A hypothetical 10% change in foreign currency exchange rates during the ~~six~~nine months ended ~~June~~September 30, 2020, between the Euro and the U.S. Dollar would increase or decrease our net income by ~~$36.1~~$52.2 million for the ~~six~~nine months ended ~~June~~September 30, 2020. A hypothetical 10% change in foreign currency exchange rates during the ~~six~~nine months ended ~~June~~September 30, 2020, between the New Israeli Shekel and the U.S. Dollar would increase or decrease our net income by ~~$8.2~~$12.4 million for the ~~six~~nine months ended ~~June~~September 30, 2020. A hypothetical 10% change in foreign currency exchange rates during the ~~six~~nine months ended ~~June~~September 30, 2020, between the Korean Won and the U.S. Dollar would increase or decrease our net income by ~~$9.6~~$10.4 million for the ~~six~~nine months ended ~~June~~September 30, 2020.

For purposes of our consolidated financial statements, local currency assets and liabilities are translated at the rate of exchange to the U.S. Dollar on the balance sheet date and local currency revenues and expenses are translated at the exchange rate as of the date of the transaction or at the average exchange rate to the U.S. Dollar during the reporting period.

To date, we have used derivative financial instruments, specifically foreign currency forward contracts, to manage exposure to foreign currency risks by hedging portions of the anticipated payroll payments denominated in New Israeli Shekels (“NIS”). Our foreign currency forward contracts are expected to mitigate exchange rate changes related to the hedged assets. Those hedging contracts are designated as cash flow hedges.

In addition, we also entered into derivative instrument arrangements to hedge the Company’s exposure to currencies other than the U.S. dollar, mainly put and call options to sell Euro for U.S. dollars, put and call options to sell U.S. dollars for South Korean Won (“KRW”) and forward contracts to sell Australian dollars (“AUD”) ~~for U.S. dollars and options contracts to sell Euro~~ for U.S. dollars. These derivative instruments are not designated as cash flow hedges.

Our trade accounts receivables potentially expose us to a concentration of credit risk with our major customers. As of ~~June~~September 30, 2020, ~~none of our customers~~one customer accounted for ~~more than 10%~~approximately 10.6% of our consolidated trade receivables, net balance. We currently do not foresee a credit risk associated with these receivables other than the amount included in our financial statements.

Credit risk as well as associated risks of defaults on payments and other bad debts could increase as a result of the impact of the economic downturn caused by COVID-19 on our customers.

Our management, with the participation of our chief executive officer and chief financial officer, evaluated the effectiveness of our disclosure controls and procedures pursuant to Rule 13a-15 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), as of the end of the period covered by this report. In designing and evaluating the disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints and that management is required to apply its judgment in evaluating the benefits of possible controls and procedures relative to their costs.

Based on that evaluation, our chief executive officer and chief financial officer concluded that our disclosure controls and procedures were effective and operating to provide reasonable assurance that information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms, and to provide reasonable assurance that such information is accumulated and communicated to our management, including our chief executive officer and chief financial officer, as appropriate, to allow timely decisions regarding required disclosure.

Following the adoption of ASU 2016-13, Financial Instruments – Credit Losses (Topic 326) on January 1, 2020, we implemented changes to our processes related to credit losses and the related control activities. There were changes to our internal control over financial reporting related to the adoption of this new standard.

Based on an evaluation by our chief executive officer and chief financial officer, such officers concluded that there have been no other changes in our internal control over financial reporting (as defined in Rule 13a-15(f) of the Exchange Act) that occurred during our most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

We have not experienced any material impact to our internal controls over financial reporting despite the fact that many of our employees were working remotely ~~during the first quarter and to a lesser extent during the second quarter,~~ due to the COVID-19 pandemic. We are continuously monitoring and assessing the COVID-19 situation on our internal controls to minimize the impact on their design and operating effectiveness.

In our Annual Report on Form 10-K for the year ended December 31, 2019 we disclosed that in May 2019, we were served with three lawsuits by Huawei Technologies Co., Ltd., a Chinese entity (“Huawei”), against our two Chinese subsidiaries and our equipment manufacturer in China. The lawsuits, filed in the Guangzhou Intellectual property court, alleged infringement of three patents and ask for an injunction of manufacture, use, sale and offer for sale, and damage awards of approximately $4.7 million. A first-instance judgment was issued on August 7, 2020 ordering the three defendants to collectively pay damages in the amount of approximately $1.55 million (including court fees) with respect of one of the patents. We believe that we have meritorious defenses to the claims asserted by Huawei and the judgement of the first instance court and have filed an appeal with the Supreme People’s Court. The first instance court’s judgement is not enforceable pending the appeal.

In September 2018, our German subsidiary, SolarEdge Technologies GmbH received a complaint filed by competitor SMA Solar Technology AG (“SMA”). The complaint, filed in the District Court Düsseldorf, Germany, alleged that SolarEdge's 12.5kW - 27.6kW inverters infringe two of the plaintiff’s patents. In its complaint, SMA requested inter alia an injunction and a determination for a claim for damages for sales in Germany. Plaintiff also asserted a value in dispute of EUR 5.5 million (approximately $6,450) for both patents. We challenged the validity of both patents. With respect to one of the claims, in October 2020, the German Patent Court rendered the SMA patent invalid. With respect to the other claim, in November 2019, the first instance court stayed the infringement proceedings since it considered it to be highly likely that the second SMA patent would also be rendered invalid. We believe that we have meritorious defenses to the claims asserted on the remaining patent and intend to vigorously defend against the remaining lawsuit.

In addition in the normal course of business, we may from time to time be named as a party to various legal claims, actions and complaints (including as a result of initiating such legal claims, action or complaints on behalf of the Company), including the matters described in Item 3 – “Legal Proceedings” of our Annual Report on Form 10-K for the period ended December 31, 2019. It is impossible to predict with certainty whether any resulting liability from any such legal claims, actions or complaints would have a material adverse effect on our financial position, results of operations or cash flows.

There have been no material changes to ~~our “Risk Factors”~~the risk factors as ~~discussed~~described in Part I, Item 1A, "Risk ~~Factors"~~Factors," in our Annual Report on Form 10-K for the year ended December 31, 2019 other than the supplemental risk factors added below:

We may not have the ability to raise the funds necessary to settle conversion of the Notes in cash or to repurchase the Notes upon a fundamental change, and our future debt may contain limitations on our ability to pay cash upon conversion of the Notes or to repurchase the Notes.

Holders of the Notes have the right to require us to repurchase all or a portion of their Notes upon the occurrence of a fundamental change (as defined in ~~Part II, Item 1A, "Risk Factors,"~~the Indentures governing their respective Notes) at a repurchase price equal to 100% of the principal amount of the Notes to be repurchased, plus accrued and unpaid special interest, if any. In addition, upon conversion of the Notes, unless we elect to deliver solely shares of our common stock to settle such conversion (other than paying cash in lieu of delivering any fractional share), we will be required to make cash payments in respect of the Notes being converted. We may not have enough available cash or be able to obtain financing at the time we are required to make repurchases of Notes surrendered or Notes being converted. In addition, our ~~quarterly report on Form 10Q for~~ability to repurchase the ~~quarter ended March 31, 2020.~~Notes or to pay cash upon conversions of the Notes may be limited by law, by regulatory authority or by agreements governing our future indebtedness. Our failure to repurchase Notes at a time when the repurchase is required by the indenture governing such notes or to pay cash upon conversion of the Notes as required by such indenture would constitute a default under such indenture. A default under the indenture governing the Notes or the fundamental change itself could also lead to a default under agreements governing our future indebtedness. If the payment of the related indebtedness were to be accelerated after any applicable notice or grace periods, we may not have sufficient funds to repay the indebtedness and repurchase the Notes or make cash payments upon conversion of the Notes.

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	September 30, 2020		December 31, 2019


Raw materials	$	116,339	$	64,714
Work in process		22,536		20,752
Finished goods		158,152		85,332

	$	297,027	$	170,798

	June 30, 2020		December 31, 2019


Raw materials	$	101,079	$	64,714
Work in process		20,839		20,752
Finished goods		142,542		85,332

	$	264,460	$	170,798

	September 30,
	2020


Liability:
Principal	$	632,500
Unamortized debt discount		(48,703	)
Unamortized issuance costs		(13,465	)
Net carrying amount	$	570,332

Equity component:
Amount allocated to conversion option	$	48,834
Deferred taxes liability, net		(11,368	)
Allocated issuance costs		(1,130	)
Equity component, net	$	36,336

	Three months ended September 30, 2020					Nine months ended September 30, 2020
	Solar		All other			Solar		All other

Revenues	$	312,480	$	25,615		$	1,030,175	$	71,476
Cost of revenues		203,590		21,283			673,751		61,974
Gross profit		108,890		4,332			356,424		9,502
Research and development		26,466		7,421			79,923		17,481
Sales and marketing		15,160		2,328			48,803		6,650
General and administrative		10,593		1,210			28,467		9,228
Segments profit (loss)	$	56,671	$	(6,627	)	$	199,231	$	(23,857	)

	Three months ended September 30, 2019					Nine months ended September 30, 2019
	Solar		All other			Solar		All other

Revenues	$	387,772	$	22,784		$	947,586	$	59,851
Cost of revenues		250,493		16,058			610,335		47,927
Gross profit		137,279		6,726			337,251		11,924
Research and development		23,707		2,754			66,219		8,235
Sales and marketing		16,551		2,256			48,900		6,273
General and administrative		7,473		2,045			21,542		6,546
Segments profit (loss)	$	89,548	$	(329	)	$	200,590	$	(9,130	)

	September 30, 2020

Amortization of debt discount	$	131
Amortization of debt issuance costs		37

Total interest expenses	$	168

	Three months ended June 30, 2020					Six months ended June 30, 2020
	Solar		All other			Solar		All other

Revenues	$	310,048	$	22,290		$	717,695	$	45,861
Cost of revenues		205,346		19,238			470,161		40,691
Gross profit		104,702		3,052			247,534		5,170
Research and development		26,374		5,852			53,457		10,060
Sales and marketing		15,020		2,179			33,643		4,322
General and administrative		8,718		2,927			17,874		8,018
Segments profit (loss)	$	54,590	$	(7,906	)	$	142,560	$	(17,230	)

	Three months ended June 30, 2019					Six months ended June 30, 2019
	Solar		All other			Solar		All other

Revenues	$	306,746	$	18,264		$	559,814	$	37,067
Cost of revenues		193,528		15,536			359,842		31,869
Gross profit		113,218		2,728			199,972		5,198
Research and development		22,280		3,039			42,512		5,481
Sales and marketing		17,149		2,307			32,349		4,017
General and administrative		7,577		2,556			14,069		4,501
Segments profit (loss)	$	66,212	$	(5,174	)	$	111,042	$	(8,801	)


(1)	Calculated based on the aggregate nameplate capacity of inverters shipped during the applicable period. Nameplate capacity is the maximum rated power output capacity of an inverter as specified by the manufacturer.

Exhibit No.	Description	Incorporation by Reference (where a report is indicated below, that document has been previously filed with the SEC and the applicable exhibit is incorporated by reference thereto)

4.1	Indenture, dated September 25, 2020, between the Company and U.S. Bank National Association, as trustee	Incorporated by reference to Exhibit 4.1 to Form 8-K filed with the SEC on September 25, 2020
31.1	Certification of Chief Executive Officer Pursuant to Rule 13a-14(a)	Filed with this report.
31.2	Certification of Chief Financial Officer Pursuant to Rule 13a-14(a).	Filed with this report.
32.1	Certification of Chief Executive Officer, pursuant to 18 U.S.C. ~~Section~~ Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002	Filed with this report.
32.2	Certification of Chief Financial Officer, pursuant to 18 U.S.C. ~~Section~~ Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002	Filed with this report.
101	The following financial statements from the Company’s Quarterly Report on Form 10-Q for the quarter ended ~~March 31, 2010,~~September 30, 2020, formatted in Inline XBRL: (i) Condensed Consolidated Balance Sheets, (ii) Condensed Consolidated Statements of Income, (iii) Condensed Consolidated Statements of Comprehensive Income, (iv) Condensed Consolidated Statements of Stockholders’ Equity, (v) Condensed Consolidated Statements of Cash Flows, and (vi) Notes to Condensed Consolidated Financial Statements.	Filed with this report.
104	The cover page from the Company’s Quarterly Report on Form 10-Q for the quarter ended ~~March 31, 2010 formatted~~September 30, 2020formatted in Inline XBRL	Included in Exhibit 101.

	SOLAREDGE TECHNOLOGIES, INC.

Date: ~~August 6,~~November 4, 2020	/s/ ~~Zivi~~Zvi Lando
	~~Zivi~~Zvi Lando
	Chief Executive Officer
	(Principal Executive Officer)

Date: ~~August 6,~~November 4, 2020	/s/ Ronen Faier
	Ronen Faier
	Chief Financial Officer
	(Principal Financial and Accounting Officer)